Our speakers

2016-2024

top

Paweł Adamkiewicz | Poland | 2018

President of the Polish Functional Rehabilitation Centre VOTUM S.A. Manager of the Healthcare Entity of the Polish Functional Rehabilitation Centre VOTUM S.A. implementing a health care programme for the treatment and rehabilitation of adult comatosed patients within the NFZ system. Vice-President of the Polish Chamber of Physiotherapists Chairman of the budgetary team of the Polish Chamber of Physiotherapists. He has been a professor at the University of Physical Education in Cracow at the Department of Rehabilitation in Neurology and Psychiatry for many years. A physiotherapist with over 20 years of professional experience in rehabilitation of patients with multi-organ traumas, in particular with craniocerebral traumas. He participated in numerous internationally recognised courses, among others on neurological rehabilitation. Member of international associations and organisations. Speaker at academic conferences and author of articles on neurological rehabilitation. top

Magdalena Ankiersztejn-Bartczak | Poland | 2023

Magdalena Ankiersztejn-Bartczak, PhD in social sciences: pedagogue, sex educator, sociologist, certified educator, HIV/AIDS consultant and counsellor, President of the Management Board of the Social Education Foundation, member of the HIV/AIDS, viral Hepatitis and Tuberculosis Civil Society Forum at the European Commission, member of the International AIDS Society, the European AIDS Clinical Society and the Polish AIDS Society (PTnAIDS), co-author of the Polish Recommendations “Principles of care for people infected with HIV”, coordinator and advisor of the Consultation and Diagnosis Points and the Mobile Harm Reduction Service, author of numerous publications and educational programmes honoured with the Red Ribbon. top

Francis Arickx | Belgium | 2017 2019

Head of the directorate Reimbursement of Medicines and Pharmaceutical Policy within the Health Care Department at the National Institute for Health and Disability Insurance (INAMI-RIZIV) in Belgium. He manages the departments responsible for administrative and scientific assessment and appraisal of reimbursement claims for medicines, orphan drugs and medical nutrition. Francis Arickx is the former secretary general for the Commission for Reimbursement of Medicines and acts as representative/expert for the Institute and Belgium on a number of national and European platforms (NM CAPR, MEDEV, MoCA). He is one of the country coordinators for the BeNeLuxA Initiative www.beneluxa.org. Francis graduated in pharmaceutical sciences from the University of Ghent, Belgium and teaches Health Policy in the Pharmaceutical Sciences Department at the University of Antwerp. top

Małgorzata Bała (SPC) | Poland | 2017 2019 2020

Małgorzata Bała, MD, PhD works at the Jagiellonian University Medical College in Cracow. She has worked on various aspects of evidence-based healthcare since the beginning of her professional career. She is the co-author of several chapters in the handbook "The principles of EBM – evidence-based medicine for doctors and students of medicine students" (2008) and published many articles on systematic reviews. top

Ewa Bandurska | Poland | 2023

Doctor of health sciences with a master’s degree in public health and economics. She is an author of numerous publications on cost effectiveness analysis, integrated care and quality of life. She has many years of teaching experience and she is the author of a unique model for educating students of Public Health in the field of pharmacoeconomics. Ewa Bandurska is the head of the Public Health – management in the health system faculty (first-cycle studies). Moreover, she is a member of the Polish Pharmacoeconomics Society (currently a member of the audit committee), the Polish Society for Health Programs, the Polish Society of Social Medicine and Public Health. She also holds the position of the supervisor of the Management and Economics in Health Care scientific club at the Medical University of Gdańsk and co-supervisor of the ISPOR Student Chapter Poland – a nationwide scientific club for pharmacoeconomics students. Furthermore, Ewa Bandurska cooperates with, among others, the National Institute of Public Health – National Institute of Hygiene, the Medicover Foundation, the World Bank and other entities. top

Marion Bennie | UK | 2021

Professor of Pharmacy and Pharmacoepidemiology, University of Strathclyde and Chief Pharmacist, Public Health Scotland. Marion’s joint post is positioned to drive forward an evidence base to better inform the safe and effective use of medicines in routine clinical care. The clinical focus of her research is infection, cardiovascular and cancer including large dataset evaluation to understand evolving patterns of medicines use in routine clinical practice and the development and impact of tailored clinical decision support tools/ health interventions. Marion has lead the provisioning and curation of the Scottish Prescribing Information System (PIS) which captures all individual level community prescribing and dispensing events for the population of Scotland (5.6million) and most recently the national collection and curation of hospital individual level data to support COVID-19 efforts to understand the use and outcome of novel COVID treatments being used in clinical care outwith the clinical trial setting. Current strategic leadership roles include; Associate Director, Health Data Research (HDR) UK Scotland; Immediate past Chair, European Drug Utilisation Research Group (EuroDURG); lead for NHS Scotland Cancer Medicines Outcome Program. Marion is a: Fellow of the Royal Pharmaceutical Society, UK ; a Fellow of the Faculty of Public Health, Royal Colleges of Physicians, UK, and; a fellow of the Royal College of Physicians, Edinburgh. top

Artur Białoszewski | Poland | 2024

Preventionist, epidemiologist, economist, public and environmental health specialist. Supreme Medical Council expert in research and analysis. Director of the Strategy and Analysis Centre of the Regional Chamber of Physicians in Warsaw and of the SGH-WUM EMBA programme in health care. Masovian voivodeship consultant in the field of Environmental Health. Academic teacher at the Department of Environmental Hazard Prevention, Allergology and Immunology of the Medical University of Warsaw and the Department of Managerial Accounting at the Warsaw School of Economics. Member of the State Examination Committee of the Medical Examination Centre. Coordinator for the development of forms of postgraduate education at the Centre for Postgraduate Education of the Medical University of Warsaw. top

Stefan Bogusławski | Poland | 2016 2019

Physician, expert on the healthcare market, specialising in financing and strategy, as well as the pharmaceutical market.
Stefan Bogusławski has over 30 years of experience in market research and healthcare market consulting. He has managed Sequence and PEX PharmaSequence for over 10 years. Before that, between 1991 and 2007, he was a manager of the Polish and Central European branch of IMS Health and was in charge of Azyx – a research company.
Stefan Bogusławski is a graduate of the Medical University of Warsaw, he obtained the title of doctor of medicine in 1985. top

André W. Broekmans MD PhD | Netherlands | 2017

André is responsible for regulatory innovation at Lygature, an independent Dutch foundation fostering public-private partnerships in the development of medicines and medical technology. He is leading the Escher project. Currently André is coordinator of the IMI project ADAPT SMART. He has built up his regulatory experience, both with an European regulatory agency (as Head of Clinical Assessment and as Chief Executive Officer at the Dutch Medicines Evaluation Board) and with major pharmaceutical companies (senior management positions with MSD, Schering Plough, Organon). top

Michał Byliniak | Poland | 2023

Michał Byliniak has been associated with the pharmaceutical market for over 15 years, acquiring extensive managerial experience in the field of distribution, reimbursement, clinical trials and registration of medicinal products. Michał Byliniak was a long-term president of the Regional Pharmaceutical Council in Warsaw, as well as the president of the Pharmaceutical Group of the European Union. Director General of the Employer’s Union of Innovative Pharmaceutical Companies INFARMA since 2022. He has experience in working in the Polish health care system, in various organisations, such as pharmacies, domestic wholesalers, pharmaceutical companies and consulting companies. He is the author of numerous studies related to the pharmaceutical sector. top

Stephen Campbell | UK | 2021 2022

Professor Stephen Campbell is Chair in Primary Care Research at The University of Manchester and until recently Director of the National Institute for Health, Greater Manchester Patient Safety Translational Research Centre. He is a health services researcher with a particular interest in the quality and patient safety of primary care and across transitional care settings including social care, with a main focus on general/family practice. He has held research appointments as Professor at the University of Melbourne, University of Canberra and the Australian National University in Australia and at the University of Heidelberg in Germany. top

Myriam de Chalendar PhD | France | 2017

Myriam is currently project manager at the French National Health Network for Rare Diseases dedicated to the congenital malformations of head, neck and teeth, in Paris. The network coordinates at the national level the actions of all the stakeholders of this group of rare diseases, in order mainly to improve the patient care, to stimulate research and to develop information, training and education. She works notably on medical classifications and rare disease coding, and on improving social care. After graduation with a PhD in molecular and cellular biology of development, she taught molecular genetics and embryology for 3 years in a French university. Afterwards, she worked several years in industry during which she specialized in information science, in particular in data classification and controlled vocabularies, in the medical field. From 2010 to 2015, she led the Orphanet disability project, at the headquarters of Orphanet, the international portal for rare diseases and orphan drugs; it aims to describe the consequences on the patient functioning of each of the rare diseases. She collaborates with EURORDIS, the European alliance of rare disease patient organizations, as scientific contributor for improving social care and promoting the incorporation of rare diseases into social services and policies in each European country. top

John Eric Chaplin | Sweden | 2019

John Chaplin is an Associate Professor and Psychologist working for the Swedish Association of Local Authorities and Regions (SALAR), and the Sahlgrenska Academy at the University of Gothenburg, Sweden. He is the project leader for the translation and implementation of patient reported outcome measures Information System (PROMIS) into the Swedish health care system, and the Swedish health quality registries. He is supervising a research project into the development of a person-centred toolbox to aid patients in the evaluation of their health care and empower them to become co-producers of care. He has worked on Quality-Of-Life and PROM issues in national and international projects including DISABKIDS, KIDSCREEN and PROMIS. He has been Principal Investigator for European projects including the EU RESPECT project reviewing children’s needs in clinical trials research. He is currently co-chair of the International Society for Quality of Life’s Special Interest Group for Children and the PROMIS National Centre leader for Sweden. top

Michał Chodorek | Poland | 2022 2023

Michał Chodorek - Attorney-at-Law, specialist in the field of Life Sciences law (including pharmaceutical law, medical devices) as well as intellectual property law and personal data protection in the Healthcare and Life Sciences industries. Michał also advises clients on manufacturing and distribution of medicinal products, e-Health and m-Health projects, conducting clinical trials, development of medical devices (including medical device software), obtaining and using medical data - including for training neural networks, data reuse from participants in clinical trials, development and implementation of AI / ML tools supporting diagnostic and therapeutic decisions. He works for leading international pharmaceutical and medical companies operating in Poland and for many industry associations, including the INFARMA Employers' Union of Innovative Pharmaceutical Companies, an association of 25 most innovative pharmaceutical companies. Author of publications on the classification of software as a medical device, the use of AI in clinical trials and the process of research and development of drugs, processing of personal data in clinical trials, co-author of international publications on Digital Healthcare and protection of trade secrets. Michał Chodorek is a member of the Polish Association for Good Clinical Practice. It is recommended in the international legal ranking The Legal 500 EMEA 2022 in the field of Healthcare & life sciences and recognized as IP Star 2022 in the field of trademarks in the ranking on intellectual property law, conducted by Managing IP. top

Oriana Ciani | Italy | 2020

Oriana Ciani is Associate Professor of Practice, Public Management and Policy Group, Health Economics & HTA at SDA Bocconi School of Management. Her research interests are centred around the use and impact of Health Technology Assessment (HTA) on decision-making in healthcare, on the methodological aspects of the evaluation of health technologies, particularly medical devices, and on the use of evidence synthesis techniques to inform policy decisions and health policies evaluation. She is also Research Fellow at the University of Exeter Medical School (UK) where she received her PhD with a thesis focusing on the evaluation of surrogate endpoints in HTA, which remains one of her main research topics. Oriana has been involved in many national and international research projects. Oriana is author of several publications in HTA, health economics and health services research and reviewer for many international academic journals. She is member of the Early Career Committee of the European Health Economics Association (EuHEA), member of HTAi, of the International Association of Health Economics (iHEA), of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR), of the Italian Association of Health Economics (AIES), of the International Federation for Medical and Biological Engineering (IFMBE) and of the Italian Association of Clinical Engineers (AIIC). Oriana holds a MSc in Biomedical Engineering from Politecnico di Milano and MSc in Healthcare Management and Economics from Bocconi University. top

Grażyna Cieślak | Poland | 2023

Grażyna Cieślak is a long-time coordinator of projects implemented in the area of health and health care, including the prevention of diabetes, colon and cervical cancer, as well as infrastructure projects introduced by public hospitals. She was responsible for administrative and financial aspects of various research and scientific projects, including “Evolvable platform for programmable nanoparticle-based cancer therapies (EVO-NANO) and “In-vivo Gene Editing by NanotransducErs (I-GENE)”. All her projects aim at determining the best value for patients. She is employed at the Gdańsk Centre for Health Promotion and Addiction Prevention and cooperates with the Polish Society for Health Programmes in Gdańsk. Grażyna Cieślak provides supervisory support to health care providers and institutions preparing and implementing health programmes. She is involved in actions advocating quality and effectiveness in the health care system, in particular in the area of lifestyle diseases. top

Justin Clark | Australia | 2023

Justin Clark is the Research Enhancement Manager at the Institute for Evidence-Based Healthcare (IEBH). He is also the Cochrane Information Specialist for the Acute Respiratory Infections Group, a member of the Cochrane Information Specialists Executive and the Co-Lead of the search group of the Living Evidence Network. He is one of the inventors of the Two-Week Systematic Review (2weekSR) method, a founding member of the International Collaboration for the Automation of Systematic Reviews (ICASR) and currently heads up the Automation Team at the IEBH. His work focuses on locating and retrieving information to minimise resources required to conduct reviews of the evidence, and he also develops tools and methods for the automation of systematic reviews. top

Joan Cornet Prat | Spain | 2021

Former Director of the ECHAlliance Digital Health Observatory (Dublin), Currently Business Development Advisor at DKV Innolab Digital Health (Barcelona), Senior Expert on the elaboration of Croatian National Digital Health Plan (2020-2025), External Expert of the European Institute of Technology - Health (Munich) and Executive Director of InnoHealth Academy. top

Kathrin Cresswell | UK | 2022

Kathrin Cresswell (KC) is a social scientist with extensive experience of conducting formative evaluations of digitally enabled change and improvement programmes in healthcare. She has consulted for the World Health Organization, Harvard Medical School, NHS England and Improvement, and is a member of the RSE Young Academy of Scotland, has received the Yvonne Carter Award for Outstanding New Researcher, and has been an invited speaker at the European Parliament and Harvard Medical School. She has over 100 peer-reviewed publications in international academic journals and almost £30 million research grant funding. She is currently Senior Lecturer at the Usher Institute at The University of Edinburgh, Co -Director of External Engagement on an EPSRC Doctoral Training Centre for Biomedical Artificial Intelligence, and Module Lead on the NHS Digital Academy teaching over 400 national and international health information technology leaders about Technology Strategy and Health Information Systems Implementation. She is also the co-chair of the International Medical Informatics Association (IMIA) and European Federation of Medical Informatics Evaluation Working Groups, providing ready access to international networks. top

Małgorzata Czajkowska-Malinowska | Poland | 2021 2022 2024

National consultant in the field of lung diseases. Head of the Department of Pulmonary Diseases and Respiratory Failure with NIV Unit and Sleep Disorders Unit, Head of the COPD and Respiratory Failure Centre at the Kuyavian and Pomeranian Pulmonology Centre in Bydgoszcz, Doctor of Medical Sciences, specialist in internal diseases and pulmonary diseases, expert in sleep medicine (certified by the Polish Sleep Research Society). President-Elect of the Polish Respiratory Society, Board Member of the Polish Sleep Research Society, Deputy Head of the Intensive Care and Rehabilitation Chapter of the Polish Respiratory Society, Member of the Non-Invasive Ventilation Group (ERS), Spokesperson for the Polish Respiratory Society since 2012. Co-author of the Polish Respiratory Society Guidelines. Member of the Pulmonary Team appointed by the Ministry of Health (2011). Medical expert in working groups of the Ministry of Health, the Agency for Health Technology Assessment and Tariff System (AOTMiT), the National Health Fund and the WHO. Author of over 100 publications in the field of pneumonology and health promotion, participant in many international multicentre works. Lecturer at pre-graduate and post-graduate training courses for doctors doing their specialisation in pulmonary diseases, balneology and family medicine. Founder and President of the Board of the “ODDECH NADZIEI dla Cierpiących na Schorzenia Płuc i Oskrzeli” foundation focusing on patients with lung and bronchial diseases, between the years 2003 and 2010 Vice-Chair of the Social Council for Persons with Disabilities to the President of Bydgoszcz. Author and coordinator of more than 20 health promotion programmes, particularly in the field of lung disease prevention and anti-smoking activities. Member of the team developing and implementing the "Interactive Programme for the Control of Nicotinism in Patients Treated in Spa Conditions". Organiser of the first COPD and Respiratory Failure Centre in Poland, the first Pulmonary Home Respiratory Treatment Centre in Poland, initiator of Non-Invasive Mechanical Ventilation (NIV) units in Poland, coordinator of the Ministry of Health policy programme entitled "National Programme for Reducing Mortality Due to Chronic Lung Diseases through the Establishment of Non-Invasive Mechanical Ventilation (NIV) Rooms for 2016-2019". She works on improving patient outcomes by developing standards of practice and applying new diagnostic and treatment techniques to lung diseases. top

Piotr Czauderna | Poland | 2016

He is head of the Department of Surgery and Urology for Children and Adolescents at the Medical University of Gdańsk. Associate professor of the Medical University of Gdańsk. In the years:

2006-2008 he was Representative of the Rector for the New University Hospital Programme at the Medical University of Gdańsk;
1996-2000 he was secretary of the General Assembly of the Polish Association of Paediatric Surgeons (PTChD),
2000-2003 – the secretary general of PTChD,
2003-2009 – head of the Gdańsk division of PTChD,
2009-2012 – President Elect of PTChD,
2012-2014 – President of PTChD;
2006-2012 he was head of the international Childhood Liver Tumours Strategy Group (SIOPEL);
2009-2015 he was Poland’s representative and member of the board of the Section of Paediatric Surgery of The European Union of Medical Specialists (UEMS)
since 2016, president of that Section.

Piotr Czauderna is also a regional consultant on Paediatric Surgery in the Pomorskie region and Coordinator of the healthcare section at the National Development Council (NRR). He graduated from the Medical Academy In Gdańsk as well as the Gdańsk Foundation for Management Development and IAE Aix-en-Provence (MBA). top

Marcin Czech | Poland | 2017 2018 2020 2024

Marcin Czech is a professor of medical and health sciences, lecturer, President of the Polish Pharmacoeconomics Society, expert in epidemiology, public health, and psychiatry.  Professor at the Warsaw University of Technology and the Institute of Mother and Child, dr. hab. n. ekon. (habilitated at the Faculty of Management at the University of Warsaw). Graduate of the MBA programme at the Warsaw University of Technology, the Study of Health Economics at the University of Warsaw, the Academy of Leadership Psychology.   He is the head of the Interdisciplinary Studies in Pharmaceutical Management, guest lecturer at the MBA SGH-WUM at the Medical University of Warsaw (WUM), where for almost 10 years he co-created the WUM Department of Pharmacoeconomics, Faculty of Management at the University of Warsaw and Lazarski University. Moreover, he is the head of the Department of Pharmacoeconomics and the head of the Hospital Infection Control Committee at the Institute of Mother and Child. Member of the Council of Experts of the Commissioner for Patients' Rights, member of the College of Public Health of the Polish Academy of Sciences. In the years 2017-2019, he was Deputy Minister of Health overseeing and co-managing the Department of Drug Policy and Pharmacy and responsible for Poland's international health cooperation. What is more, he is the author of over 300 papers and reports and 10 books on management, health economics, pharmacoeconomics, and quality of life, published in both foreign and Polish journals. His interests include travel, geopolitics, film, diving, sailing, and skiing. top

Aleksandra Czerw | Poland | 2020

Head of the Department of Health Economics and Medical Law of the Medical University of Warsaw. Head of the Department of Economic and System Analyses of the National Institute of Public Health – National Institute of Hygiene (NIZP-PZH). Member of Scientific Societies and editorial committees in international journals. Author of reviews of scientific publications in domestic and foreign journals. She has received awards and distinctions of the President of the Republic of Poland, the Minister of Education for her activities and has received awards from various organisations operating in the health care system. Scientific interests: health economics, healthcare management, financing in the healthcare system, measuring quality of life in chronic diseases. top

Dávid Dankó | Hungary | 2016 2018

Managing director, Ideas & Solutions (I&S), research leader, Corvinus University of Budapest Dávid Dankó is managing partner of Ideas & Solutions (I&S), an independent research and consultancy firm which provides health policy and market access advisory services to health insurance organizations and pharma and medical device companies with a focus on emerging and middle-income markets. Dávid has 15 years of experience in health care management & the funding of pharmaceuticals and medical devices. Until 2010 he was member of the executive team for pharmaceutical reform in Hungary as Deputy Director of Reimbursement at the national health insurance fund. Previously he also held a position as research leader at the Corvinus University of Budapest. He speaks regularly at conferences and workshops on pharmaceutical and medical device policies, gives payer communication and negotiation trainings to multinational companies and authorities, and participates at international advisory boards. Focuses:

Pricing of targeted onco-hematology medicines
Pragmatic value assessment and HTA systems for middle-income markets
Designing managed entry agreements and linking them to value assessment
Negotiations and communication with payers and other governmental stakeholders
Alternative funding strategies for middle and low-income countries

Dávid lectures in the European Market Access University Diploma (EMAUD) programme, at the Vienna School of Clinical Research (VSCR) and in pharmacy and health economics courses across Central Europe, Russia and the Middle East. He graduated in Economics from Corvinus University of Budapest where he also earned his PhD degree in 2012 with a thesis on resource management in pharmaceutical research & development. Dávid is peer-reviewer and editorial board member of three health economics and market access journals. He is also co-editor of a university textbook titled ‘Pharmaceutical Reimbursement’ and co-author of the Pharmacoeconomics and Outcomes Research Guidelines for India. Dávid works in English, Russian and Italian, and also speaks German, French and Portuguese. top

Hans-Peter Dauben | Germany | 2020

Dr. Hans-Peter Dauben, born in Moenchengladbach, Germany, is a civil servant at the German Institution for Medical Documentation and Information (DIMDI), Cologne, Germany, an institution within the scope of the Federal Ministry of Health. After finalizing his training as a cardiac surgeon at the University of Duesseldorf, Germany, he moved to DIMDI to establish the German Agency for HTA at DIMDI on behalf of the federal ministry in 2000 and to develop a structure to access HTA information, set priorities in HTA and monitor new technology developments to establish a broad consensus on HTA in Germany. The experiences of information systems developments lead to the nomination of Dr. Dauben as the national representative for information system development at the European medicine agency (EMEA) in London, UK. top

Jaroslav Duba | Czech Republic | 2016 2018

Jaroslav founded OAKS Consulting s.r.o. in 2009, after more then 15 years of experience in top management positions in Wyeth, Zentiva and Glaxo. OAKS Consulting has became in short time the leading consulting company providing full scope of services in Market Access in Czech Republic. The team currently consists of 15 specialists with professional background in medicine, pharmacology, mathematical modeling and health-economy.
top

Dominik Dziurda | Poland | 2017 2018 2020 2021

Director of the Healthcare Services Department at the Agency for Health Technology Assessment and and Tariff System (AOTMiT). He graduated from the Faculty of Pharmacy at Jagiellonian University Medical College (CMUJ) in Cracow (2002) and the post-graduate programme: MBA for Medical Personnel at the Kozminski University in Warsaw (2010). Doctoral Student at the Warsaw School of Economics (SGH). His work experience includes teaching at universities on subjects related to pharmaceutical law, pharmacoeconomics and organisation of the healthcare system. He has also worked as reimbursement director in national and central structures in the pharmaceutical industry and as an analyst and specialist in projects regarding access to medical care and quality management. President of the technical unit in the Fair and Affordable Pricing project, implemented within the Visegrad Group, a member of the Executive Committee of the POINTer project dedicated to the system of quality indicators. At the AOTMiT he is responsible for i.a. projects related to transformation of the guaranteed services system, with focus on medical rehabilitation, coordinated care and issues concerning clinical practice guidelines. top

Joanna Didkowska | Poland | 2020

She has been involved with the Department of Epidemiology of the Oncology Centre in Warsaw since the very beginning of her professional work. Currently, she is the head of the Department of Epidemiology and Cancer Prevention, as well as the head of the National Cancer Registry. Since 2016, she has been the Director of the WHO Collaborating Center for Tobacco Control and a member of the National Council for Oncology at the Minister of Health. She represents the Oncology Centre at the Marie Skłodowska-Curie Institute in Warsaw at the Governmental Population Council. Member of the Public Health Committee of the Polish Academy of Sciences. She participated in population studies concerning risk factors for cancer incidence (tobacco, alcohol, diet, demographic processes), and monitoring the geographical diversification of the incidence and mortality related to malignant neoplasms in Poland. She was the initiator and co-author of studies analysing the survival rate of Polish patients. She co-authored a yearly bulletin on malignant neoplasms in Poland, as well as a study on epidemiological forecasts. She is a member of the Polish TNM Committee of the Union for International Cancer Control (UICC, previously International Union Against Cancer), the Polish Oncological Society, Polish Oncological Union, as well as the Polish Breast Cancer Research Society. Since 2011, she has been section editor in “NOWOTWORY Journal of Oncology” and, since 2016, a member of the editorial team of “Oncology in clinical practice”. She authored over 60 publications.
top

Karen Facey | UK | 2018 2023

Karen Facey worked as a statistician in pharma and medicines regulation, before becoming CEO of the first national HTA Agency in Scotland. For the past 20 years, she has worked as an international consultant in HTA, with special interests in use of real world data, evaluation of rare disease treatments and patient involvement. She is senior advisor for HTA at FIPRA, providing secretariat to the payer-led learning network, RWE4Decisions. top

Carla Fernández Barceló | Spain | 2019

Carla is a Health Technology Assessment Technician of the Innovation Unit at Hospital Clínic de Barcelona, a high-tech hospital and a reference for health care, research and medical training in Spain. In her everyday job, she works with different projects (technologies, services) assessing both the clinical and economic outcomes, to prove the value of health care technologies that are being developed inside the hospital as well as new technologies candidate to be introduced in the Hospital. Prior to this, Carla Fernandez was enrolled in d·Health Barcelona (Moebio, Biocat) a post-graduate program targeting innovation in healthcare, where she developed a 18-months project going through all the steps of the healthcare innovation cycle (detect a problem, create a solution, prototype, develop a business model and investor’s pitch to fund it). Contact with the healthcare innovation sector from a start-up perspective showed her a perspective that is useful in working in the HB-HTA department and which complemented her previous knowledge about innovation; the “seller/start-up” perspective was complemented by the “buyer/hospital” perspective. top

Wolfgang Frisch | Germany | 2016

Wolfgang is a member of the management board of Medtronic Germany GmbH and is responsible for the areas of health economics, market access and health policy. He develops and evaluates strategies for Medtronic therapies and products, the market launch and initiates with the decision makers from medicine, politics and health insurance the establishment of new forms of cooperation for patient care. Due to the wide product spectrum of Medtronic GmbH, Mr. Frisch has experience in the field of inpatient, and ambulatory care. Mr. Frisch has been working in the medical technology industry for over 20 years. He was responsible for business development for Stryker GmbH & Co. KG in Germany, Austria and Switzerland and was responsible for the national key account and corporate account management of Dräger Medical AG. top

Kamila Gaitova | Kazahstan | 2018

Head of HTA department of Republican Center for Health Development of the Ministry of Health of the Republic of Kazakhstan. She graduated from the Kazakh National Medical University in Almaty. She has a PhD in Public Health. When she started work at RCHD her main activity were promoting EBM and developing clinical practice guidelines. She is a co-author of several national CPGs and clinical protocols. Since 2016, her responsibility in RCHD has become conducting HTA on national level in order to support decision-making process trough providing an evidence based information for policy-makers in Kazakhstan. She is a Member of HTAi and participated HTAi and INAHTA Annual Meetings in 2017-2018. top

Krzysztof Giannopoulos | Poland | 2020

Professor, Ph.D. Krzysztof Giannopoulos is head of the Department of Experimental Haematooncology at the Medical University of Lublin and head of the Department of Haematology at the St. John of Dukla Oncology Center in Lublin. He was appointed Director of the Doctoral School of the Medical University of Lublin for the 2020-2024 term. Professor Giannopoulos is an expert in clinical and experimental haematology. In his scientific research, he focuses on molecular biology and the characteristics of immune processes in the course of proliferative haematological diseases. The results of the first clinical trials of immunotherapy and treatment with immunomodulating drugs in patients with chronic lymphocytic leukaemia, multiple myeloma and acute myeloid leukaemia have been published in prestigious journals such as: Blood, Leukemia, Haematologica, British Journal of Cancer, British Journal of Haematology. He is the author and co-author of recommendations on the treatment of haematological cancer patients and chapters in medical textbooks. His academic achievements have been awarded with numerous prizes, including: Award of the Prime Minister, Award of the Minister of Science and Higher Education, Award of the “POLITYKA” weekly, Award of the International Society of Haematology (IHS), as well as the Bene Meritus Terrae Lubliniensi Award. The h-index of his total scientific achievements amounts to 23. He presented scientific papers at the most important haematological conferences in Poland and abroad. He received scientific grants from the Else-Kröner-Fresenius Foundation, the Minister of Science and Higher Education, the National Science Centre and the Foundation for Polish Science, such as: HARMONIA, OPUS, START, POWROTY, KOLUMB and FOCUS, the latter for the creation of a research team in the field of oncology. He spent a total of 3 years on scientific scholarships financed by DAAD, KAAD and the Foundation for Polish Science at the Department of Internal Medicine III at Ulm University (Germany) headed by Prof. Hartmut Döhner. Professor Krzysztof Giannopoulos is the co-founder and first chairman of the Youth Section of the Polish Society of Haematologists and Transfusiologists, co-founder and the first chairman of the New Generation of Haemathology Association, co-founder and member of the board of the Polish Myeloma Consortium, a representative of the Praesidium of the Polish Myeloma Group, a member of the board of the Polish Lymphoema Research Group and a member of the Scientific Council of the Institute of Haematology and Transfusion in Warsaw, the Programme Council for Biomedicine at the Medical University in Warsaw in Lublin, Study of Molecular Medicine at the Medical University of Warsaw and the Social Council for Health Protection of the Lubelskie voivodship. In 2011-2019, he was the editor-in-chief of “Acta Haematologica Polonica”. In 2019, he received the Medal of the Centenary of Regained Independence for his outstanding achievements in the healthcare sector and was ranked among the 100 most influential people in medicine in Poland. top

Jakub Gierczyński | Poland | 2019

Doctor of medicine and MBA graduate of London School of Economics and Stockholm Business School. Expert with 20 years of experience in health economics, public health, disease management, decision analysis, medical audits, risk management (Burton, EBM, HTA and VBHC). Co-funder of the Polish Pharmacoeconomic Society, member of the Polish Society for Public Health, HTAi, ISPOR, the Polish Coalition for Personalised Medicine and IFIC Polska. Co-author of Polish HTA guidelines for drug technologies and member of the team preparing Polish HTA guidelines for medical devices. Author of several dozen of publications, studies and reports.https://www.researchgate.net/profile/Jakub_GierczynskiMember of international projects in the field of health policy, disease management and health economics. Expert and lecturer at the Institute of Health Care Management, the Health Care MBA and the Center of VBHC at the Łazarski University, He is also the owner of Doradztwo i ekspertyzy. top

John Gillespie | Australia | 2018

Healthcare Economics, Health Policy & Reimbursement, Medtronic Australasia, Sydney Dr Gillespie received his PhD from the University of Dundee, Scotland and continued his research on protein phosphorylation and metabolic control at the University of Edmonton, Canada. After moving to Sydney, he changed careers - moving into the field of healthcare economics. Dr Gillespie spent several years in consultancy where his main responsibility was conducting health technology assessments (HTA) of new medical technologies and procedures for the Australian Department of Health and Ageing. Since joining Medtronic his responsibilities have included health economics and reimbursement projects for cardiovascular and neurovascular technologies. His main area of responsibility is once again HTA of new medical technologies and procedures. He is particularly interested in how HTA needs to change to remain relevant when medical technologies, healthcare practice and evidence are continuously evolving. top

Maria Giżewska | Poland | 2021

Prof. Maria Giżewska is a graduate of the Pomeranian Medical Academy. She obtained her specialisation in paediatrics in 1993, metabolic paediatrics in 2014. She received her doctoral degree in 1995 and was habilitated in 2009. She was awarded the title of Professor of Medicine in 2019. Prof. Giżewska is a consultant in metabolic paediatrics for the West Pomeranian Voivodeship, Deputy Head of the Department of Paediatrics, Endocrinology, Diabetology, Metabolic Diseases and Cardiology of the Developmental Age, plenipotentiary of the Rector of the Pomeranian Medical University in Szczecin for international cooperation. Her main scientific interests concern diagnostics and treatment of rare and ultra-rare diseases, including congenital metabolic disorders, especially phenylketonuria, and newborn screening. She is the author and co-author of more than 120 national and international scientific publications with a total IF score of 160 points, Hirsch index 16. Prof. Giżewska implements cross-border Polish-German scientific projects co-financed by the Interreg IVA and VA programmes from the EU funds at the Pomeranian Medical University (PMU) and the Independent Public Clinical Hospital No.1 of the PMU in Szczecin. The cooperation is dedicated to early diagnosis and treatment of newborns with rare diseases, including congenital metabolic disorders, endocrine disorders and recently also congenital immunodeficiency disorders. She is a member of numerous national and international scientific societies (Vice-President of the Scientific Committee of the European Society for Phenylketonuria (ESPKU) and Vice-President of the Polish Society of Phenylketonuria). top

Brian Godman | UK | 2016 2017 2021 2022

Brian works with the World Health Organization, governments, health authorities and health insurance companies across continents including Africa, Asia, Europe, Middle East, and South America to enhance prescribing efficiency within scarce resources. This includes potential ways to value and fund new medicines including those for cancer and orphan diseases incorporating suggested models to optimize their use post launch. This has resulted in multiple publications (over 150 listed in Pub Med since 2008) and presentations to address these key issues. top

Wim Goettsch | Netherlands | 2016

Current Director of the European Network for Health Technology Assessment (EUnetHTA) JA3 Directorate. Between 2010 and 2015 he was the Project Leader of WP5 of the EUnetHTA JA1 and JA2 on Relative Effectiveness Assessments. Until the beginning of 2013, he was also the Deputy Secretary of the Medicinal Products Reimbursement Committee at Dutch National Health Care Institute. He has a PhD in immunology and an advanced education in (pharmaco)-epidemiology and pharmaco-economics. He has more than 70 publications in peer-reviewed international journals. top

Anaïs González Iglesias | Spain | 2024

Anaïs González Iglesias is a Business development consultant with extensive experience in Healthcare, particularly in Precision Medicine & Genomics. She holds a PhD in Computational Physics and is currently pursuing a PhD in Economics. Additionally, she holds a Master's degree in Health Economics and Pharma Economy, as well as a specialization in Bioinformatics, Genomics, and Molecular Biology.. Beyond her academic achievements, Anaïs actively contributes to the community as a mentor in several Acceleration Program and serves as an external evaluator for various EU-funded programs. top

Clifford Goodman | USA | 2023

Dr Clifford Goodman jest niezależnym konsultantem w dziedzinie technologii i polityk zdrowotnych. Uprzednio pełnił funkcję Wiceprezesa w The Lewin Group (spółka Optum oraz spółka zależna UnitedHealth Group), firmie konsultingowej ds. polityki zdrowotnej, z którą był związany przez 27 lat. Dr Goodman posiada czterdzieści lat doświadczenia w obszarach takich jak ocena technologii medycznych, opieka zdrowotna oparta na dowodach, wytyczne praktyk klinicznych, ekonomika zdrowia oraz nauki związane z innowacją, regulacjami i płatnościami w opiece zdrowotnej. Prowadził badania i projekty na międzynarodową skalę dla agencji rządowych; spółek zajmujących się farmaceutyką, biotechnologią i wyrobami medycznymi; instytucji dostawy opieki zdrowotnie; oraz zawodowych i branżowych grup interesu, a także grup interesu pacjentów. Ostatnio jego praca obejmuje obszary takie jak choroby przewlekłe, choroby zakaźne, nowotwory, choroby rzadkie, badania diagnostyczne, terapia genowa, farmakogenomika, medycyna spersonalizowana, leki biopodobne, kontraktowanie oparte na wartościach, społeczne uwarunkowania zdrowia i stosowanie rzeczywistych danych.

Dr Goodman pełnił funkcję przewodniczącego amerykańskiego komitetu Medicare Evidence Development and Coverage Advisory Committee (MEDCAC, 2009-12) dla agencji US Centers for Medicare and Medicaid Services (CMS). Ponadto, pełnił funkcję prezesa społeczeństwa zawodowego, Health Technology Assessment international (HTAi, 2011-13) oraz jest członkiem American Institute for Medical and Biological Engineering (AIMBE). W 2022 r. otrzymał nagrodę David Banta Distinguished Career Award w ocenie technologii medycznych od HTAi. Zdobył tytuł doktora w Wharton School of the University of Pennsylvania, tytuł magistra w dziedzinie nauk ścisłych na Instytucie Technicznym Georgii (Georgia Institute of Technology) oraz tytuł licencjata w dziedzinie nauk humanistycznych na Uniwersytecie Cornella. top

Alicia Granados Navarrete | Spain | 2016

Since 2011 Head of Global Health Technology Assessment (HTA) Scientific Strategy at Sanofi Genzyme, company based in Cambridge, Massachusetts. Researcher and associate professor at the School of Medicine of University of Barcelona until 2007, entrepreneur, international specialist in technology assessment and health care systems, was responsible for the creation and management of the Catalan Agency for Health Technology Assessment and Research (CAHTAR). Director and general manager of the Catalan Institute of Health (ICS) and later Leader of the Health Evidence Network (WHO – European Regional Office). Bioregió (BIOCAT) Ambassador and of the International Society for Health Technology Assessment (HTAi) of which she was founder. She has been president of Forética and has more than 60 scientific and health care policy papers published in international peer review journals. Former President of Autonomous University of Barcelona’ Board of Trustees. Currently Dr Granados is also member of the Advisory Council for the Economic Growth of Catalan Autonomous Government since its creation in 2011 and since 2014 she also serves as President of Scientific Advisory Committee of AquAS (Catalan Agency for Quality and HTA). top

Sylwia Grzesiak-Ambroży | Poland | 2018

Graduated from the Faculty of Health Protection, Collegium Medicum, Jagiellonian University for public health, completed doctoral studies. She started her professional career from the beginning with the Department of Health and Social Policy of the Marshal Office of the Malopolska Region in Cracow, where she started work in 2004. She implemented solutions aimed at popularizing health prevention and shaping the model of health care tailored to Małopolska needs. Initiator of Malopolska Days of Health Prevention. Currently, as Director of the Department, he is involved in the development of a regional health care system that improves the health and quality of life of patients. top

Iñaki Gutiérrez-Ibarluzea | Spain (Basque Region) | 2024

Iñaki Gutierrez-Ibarluzea has a degree in Fundamental Biology and a PhD in Neuroscience from the University of the Basque Country. University Specialist in Clinical Epidemiology from the Andalusian School of Public Health and the University of Granada and Master in Bioethics from the Ramon Llul University and the Borja Institute of Bioethics and a Master on Health Innovation Management from the University of Nebrija (Madrid) and Idival. He is the Head of Knowledge Management and Evaluation of BIOEF, the Basque Foundation for Healthcare Innovation and Research, past-President of the international society HTAi (2019-2021) and the President of EuroScan/iHTS, the international network for the identification and early assessment of technologies in their life cycle since 2020. Guest Director of HTA and Market Access at Healthclusternet. Iñaki has collaborated in the implementation of HTA initiatives in different countries including Argentina, Brazil, Colombia, South Korea, Costa Rica, Ghana, Vietnam, Mexico, South Africa, Tunisia, Norway, Israel, USA, Malaysia and Italy (Early Warning System). He has also collaborated with the regional offices of the World Health Organization (WHO) in the Middle East (EMRO), Asia Pacific (WPRO) and Latin America (PAHO). WHO Consultant Expert for the Assessment of Emerging Health Technologies and Medical Devices. top

Alan Haycox | UK | 2017

Reader in Health Economics and Director of Liverpool Health Economics and Visiting Professor at Hacettepe University (Ankara) Dr Haycox is a Global Health Economics expert who achieved a four star assessment in the 2015 RAE. He has extensive experience of applying health economics in practice including five years as a member of the Appraisal Committee of the National Institute for Health and Care excellence (NICE) and five years as Regional Health Economist in the North West of England. Widely acknowledged international expert on HTA who has been a keynote speaker on Health Technology Assessment in over 27 countries in the past ten years. Over 140 publications, 3 published books with a fourth currently awaiting publication. Editorial Board Member and referee for over 50 international journals. Co-applicant on research applications valued at over Ł2,000,000 in the last five years and expert reviewer for the NIHR, MRC and a wide range of national and international research funding bodies. Extensive experience in developing and implementing structures of Health Technology Assessment and associated training in a wide range of middle and low income countries. Established expertise in the development of health economic programmes at the undergraduate, postgraduate and executive training levels. Currently leading the UK programme in the establishment of an international postgraduate programme in Health Technology Assessment funded by the Erasmus Mundi Programme in collaboration with five other Universities throughout Europe. Dr Haycox has extensive experience and expertise in health economic evaluations in a broad spectrum of disease groups and interventions. In addition to publishing extensively in peer reviewed journals such as the BMJ and Pharmacoeconomics, Dr Haycox has authored a large number of Health Technology Assessment Monographs. Dr Haycox is a founding director of the Liverpool Technology Assessment Reviews unit which works directly on evaluations to inform decision making by NICE. For the past four years he has been a member of the NICE Technology Appraisal Committee which decides on the introduction of new drugs into the British National Health Service. top

Mikael Hoffmann | Sweden | 2016

CEO of the NEPI foundation initiated by the Swedish Parliament in order to promote pharmacoepidemiology and health economics, co-localized and in close collaboration with the National Centre for Priority Setting in Healthcare. Specialist in clinical pharmacology and in infectious diseases/internal medicine. Chairman of the standing committee for pharmaceutical policies of the Swedish Society of Medicine. Member of the scientific advisory board of the Medical Products Agency in Sweden. Former member of the pharmaceutical benefit board of the Dental and Pharmaceutical Benefits Agency, TLV. Former member of the steering group of e-health at Swedish Association of Local Authorities and Regions. Former director of pharmaceutical strategies, County Council of Östergötland. top

Tomasz Hryniewiecki | Poland | 2023

Tomasz Hryniewiecki is cardiologist and specialist in internal medicine. He holds the position of Representative to the Minister of Health for the National Cardiovascular Disease Programme 2022-2032. National consultant for cardiology. Professor Hryniewiecki is professionally and academically associated with the Cardinal Stefan Wyszyński Institute of Cardiology – National Research Institute, where he has been head of the Heart Valve Defects Clinic for 12 years. He was Director of the Institute from 2015 to 2022, which he transformed into a National Research Institute with the highest scientific category A+ and initiated its major modernisation.  In 2020, Professor Hryniewiecki started to prepare the National Cardiovascular Disease Programme for 2022-2032. At the same time, he has started work on a programme of comprehensive and coordinated cardiac care, the “National Cardiac Network”, which is designed to facilitate the patient’s journey from primary care to diagnosis and modern treatment in appropriate specialist healthcare facilities. He is the author of numerous scientific papers, textbooks, and the editor-in-chief of journals, as well as scientific director of congresses. He is a fellow of the Polish and European Society of Cardiology. top

Erica Ison | UK | 2019

Erica works at the Oxford Centre for Triple Value Healthcare (3V) in England. She has a decade’s experience in using the identification of unwarranted variation to increase value in the provision and delivery of health services. She was the Editor the NHS Atlases of Variation in Healthcare since the first compendium Atlas appeared under the English Department of Health’s Quality Innovation Improvement & Prevention (QIPP) programme in 2010. Since then, Erica has overseen the writing, editing and production of three compendium atlases and six specialist atlases, covering Liver Disease, Kidney Care, Children and Young People, Diagnostic Services, Respiratory Disease and Diabetes. Erica is currently working on two projects in the National Health Service (NHS) to increase value in healthcare, one of which is focused on end-of-life care, and the other is focused on people with musculoskeletal conditions. On behalf of 3V, she will also be working on the European Union-funded ExACT Project for the next 4 years, collaborating with universities in Italy, The Netherlands, and Belgium together with other stakeholders in the healthcare sector. In addition, Erica is the lead, and also a facilitator/trainer, for the Critical Appraisal Skills Programme (CASP) run by 3V. Erica is a specialist in Health Impact Assessment (HIA) and in Health in All Policies (HiAP). Since 2003, she has worked as an expert adviser in HIA for the World Health Organization (WHO), and similarly in HiAP since 2008, and in the last few years has worked on three major projects relating to the health impacts of the construction and operation of nationally significant infrastructure for Public Health England. Erica was also part of the Global Burden of Disease (GBD) team for Public Health England (PHE) for two years. In 2005, Erica won the Individual Award in Impact Assessment from the International Association for Impact Assessment, and in the same year was made an honorary member of the English Faculty of Public Health. top

Inna Ivanenko | Ukraine | 2023

Inna has graduated from School of Social Work of Kyiv-Mohyla Academy National University in 2007 and since then her career is developing in social and humanitarian spheres. From 2007 till 2012 Inna was working in the Policy and Advocacy Department of All-Ukrainian Network of People Living with HIV, combating for ARV-treatment availability for those who needed it. In 2012 Mrs Ivanenko became one of the founders of patients based organization CF “Patients of Ukraine” and in 2018 was elected as its Executive director. CF “Patients of Ukraine” is a unique organization, uniting 50 members, who are leaders of patients organizations from 23 disease areas. Organization is a strong advocate for treatment access, anti-corruption medical procurement reform and overall healthcare reform in Ukraine, representing interests of more than 1,5 million patients with severe diseases. During full-scale war in Ukraine CF “Patients of Ukraine” is among leaders who helps to overcome Ukrainian patients and healthcare system the consequences of russian invasion. top

Stanisław Iwańczak | Poland | 2021

Stanisław Iwańczak, MSc, Plenipotentiary of the Director for Patient Safety at the Katowice Oncology Centre. Laboratory diagnostician, Graduate of the Pharmaceutical Department of Medical Analytics in Sosnowiec. In the years 1999-2018, Head of the Diagnostics Laboratory at the Katowice Oncology Centre. In the years 1995-1999, employee of the Pharmaceutical Quality Control Laboratory in Katowice. In the years 2010-2014, Deputy Disciplinary Ombudsman of the National Chamber of Laboratory Diagnosticians. Four years ago I became passionate about Patient Safety. I try to share the full scope of this discipline with others. I am constantly looking for people and institutions genuinely interested in implementing patient safety solutions in Poland and around the world. top

Michał Jakubczyk | Poland | 2019

Professor of the Warsaw School of Economics. He works in the Department of Decision Support and Analysis of the Warsaw School of Economics (SGH). He is also the co-owner of a consulting company called HealthQuest (www.healthquest.pl). He has a background in economics (MSc, PhD and habilitation in the Warsaw School of Economics) and mathematics (bachelor at the University of Warsaw). He spent a year in the Centre for Operations Research and Econometrics in Louvain-la-Neuve, Belgium (Marie Curie scholarship) and one semester in Tippie College of Business, University of Iowa, USA (Fulbright Senior Award). His scientific interests include researching health preferences, especially in the context of imprecise description of these preferences. He has published numerous scientific articles in the field of decision support, health economy and general decision theory (among others, in the Annals of Operations Research, Central European Journal of Operations Research, Health Economics, Pharmacoeconomics, Quality of Life Research, Value in Health (cf.: http://michaljakubczyk.pl)). He is a member of scientific associations such as The EuroQol Group and the International Academy of Health Preference Research (IAHPR). He led the winning team in the global health preference and choice modelling competition organised by IAHPR (http://iahpr.org/eq-dce-competition/). He gives lectures on decision analysis at bachelor, master’s and MBA levels, as well as training cuorses for various institutions (e.g. the National Health Fund, the Ministry of Health, the Agency for Health Technology Assessment and Tariffs, private companies). He co-directs the MBA programme offered jointly by the Warsaw School of Economics and the Medical University of Warsaw. top

Krzysztof Jakubiak | Poland | 2022

The founder and the president of the management board of the Modern Healthcare Institute, the editor-in-chief of the mZdrowie.pl portal and the “Obserwacje MHI” (MHI Observations) magazine. In the past, among others, he was as the spokesperson of the Ministry of Health and the Ministry of Finance, the editor-in-chief of “Puls Medycyny” and “Puls Farmacji”, the manager responsible for communication and PR in companies such as Polpharma, Coca-Cola, Henkel and Lafarge. Krzysztof Jakubiak graduated from the University of Warsaw (the Faculty of Polish Studies), the University of Wisconsin (management), Higher School of Management – Thames Valley University (now: University of West London). top

Jerzy Jaroszewicz | Poland | 2024 |

Professor Jerzy Jaroszewicz, specialist in infectious diseases and hepatologist, is Head of the Clinical Department of Infectious Diseases and Hepatology of the Medical University of Silesia in Katowice. Moreover, he acts as President of the Polish Association for the Study of the Liver, is a member of the Polish Groups of Experts for HBV, HCV, COVID-19 and for Non-Alcoholic Fatty Liver Disease (NAFLD) and is a member of the HBV expert panel of the European Association for the Study of Liver (EASL).  He specialises in diagnosis and treatment of HAV, HBV, HCV, HEV, autoimmune, steatotic, genetic and other liver diseases (research on infectious diseases). He is also involved in the treatment of tick-borne diseases (including Lyme borreliosis), other viral, bacterial, and fungal infectious diseases and immunoprophylaxis. He graduated from the Medical University of Bialystok in 1999. He acquired his scientific skills during numerous internships abroad (Aachen, Germany and Florence, Italy) in the field of pathophysiology and liver cell culture techniques, among others. In the years 2008-2010, he carried out research under grants (DAAD, Erasmus, Deutsche Leberstiftung) at the Clinic of Gastroenterology, Hepatology and Endocrinology of the Hannover Medical School. He is the author and co-author of more than 150 publications in journals on the Philadelphia List, numerous chapters in textbooks and conference reports on primarily clinical and molecular aspects of viral hepatitis. top

Urszula Jaworska | Poland | 2018

In 1997, she became the first patient in Poland to receive a bone marrow transplant from an unrelated donor. That surgery, groundbreaking in the history of Polish medicine, was performed in the Department of Haematology of the Medical University of Silesia in Katowice, by Prof. Jerzy Hołowiecki with the team. It was the experience of fighting for her own life that inspired her to create a foundation which, since 1997, has been actively helping patients suffering from cancer, leukaemia, MS, hepatitis C, multiple myeloma, brain cancer; it develops a bone marrow donor bank, organises educational and information initiatives in the media, as well as pro-patient changes in the health care system. For many years, the organisation was also the largest Bone Marrow Donor Bank in Poland in terms of the number of registered people. It is thanks to the personal devotion on the part of Urszula Jaworska and the entire foundation team that the idea of bone marrow donation became so popular in Poland. The foundation's register currently has over 11,000 bone marrow donors. Despite numerous duties, she tries to combine work in the foundation with supporting other organisations, including OFOP and other patient associations. For several years, she has been active under the office of the Commissioner for Patients' Rights as a Member of the Social Council of the Commissioner for Patients' Rights. She was ranked 38th in Puls Medycyny's 2017 list of the 100 most influential people of the Polish health care system. Since February 2018, she has participated in the work of the Health Committee of the Polish Chamber of Commerce. She is a graduate of the National Ballet School in Warsaw and a student of the Fryderyk Chopin University of Music in Warsaw in the Department of Ballet Pedagogy. She is a dancer and a soloist, as well as the manager of many significant ballet ensembles, including: Syrena, Sabat, Mazowsze. In 1994, she was diagnosed with leukaemia. As the first patient in Poland to ever receive a bone marrow transplant from an unrelated donor, she became the Founder of the Urszula Jaworska Foundation. She actively participates in organising activities aimed at broadly understood assistance offered to patients with leukaemia, other cancers and chronic diseases. She attaches great importance to raising social awareness regarding cancer. top

Tadeusz Jędrzejczyk | Poland | 2019 2022 2023

Director of the Health Department of the Pomeranian Voivodeship Marshal's Office. Graduate of the Medical Faculty of the Medical Academy in Gdańsk (nowadays known as the Medical University of Gdańsk). Specialist in Public Health. He has a PhD in medical sciences and holds the position of assistant professor in the Department of Public Health and Social Medicine. Author of several dozen articles on public health concerning, in particular, the field of management and organisation of health care, economic aspects and epidemiology. Councilor of the City of Gdańsk (1994-1998) and chairman of the City Commission for Solving Alcohol Problems (1997-2001). Deputy Healthcare Director at the University Clinical Centre in Gdańsk (2010-2014), Deputy Director and then Director of the Pomeranian Branch of the National Health Fund (2008-2009 and then 2013/14); President of the National Health Fund between June 2014 and March 2016. top

Bradley Johnston | Canada | 2018

Dr. Bradley Johnston (PhD) is the director and co-founder of NutriRECS (www.nutrirecs.com), and is an Associate Professor with the Department of Community Health & Epidemiology, Faculty of Medicine, Dalhousie University, Halifax, Canada. He also holds adjunct appointments with The Hospital for Sick Children (SickKids) Research Institute, where he founded the SickKids evidence synthesis unit (SORT - Systematic Overviews through advancing Research Technology), and the Department of Health Research Methods (formally Clinical Epidemiology & Biostatistics), McMaster University, where he is a tutor in the annual Evidence-Based Clinical Practice Workshop. Dr. Johnston is an Associate Editor with BMC Medical Research Methods. Dr. Johnston’s academic interests include the methodology of patient-reported outcome measures, randomized trials, systematic reviews and public health practice guidelines. His work involves the application of these methods to a wide range of areas, with a particular interest in the education, principles and practice of evidence-based nutrition. He has published over 100 peer-reviewed articles, including first and senior authored articles in JAMA, Annals of Internal Medicine, CMAJ and Pediatrics. top

Mateusz Juchniewicz | Poland | 2021

Professor at the Warsaw School of Economics (SGH), Head of the Project Management Department at SGH. Graduate of Management and Marketing at the Warsaw School of Economics. Director and lecturer of Postgraduate Project Management Studies, other postgraduate and MBA studies. Director and participant of research, consulting (e.g. Building an organisation’s project maturity), implementation (e.g. implementation of methodologies, project management offices, business process improvement) and training projects. He cooperates with both the public sector (e.g. the Chancellery of the Prime Minister, the Ministry of Infrastructure, the Supreme Audit Office, other units of the public finance sector) and the private sector (mainly companies from the energy, transport, R&D and construction sectors). He specialises in project management maturity, project risk management and projects in multicultural environments. Author of several dozen publications in the field of management, including the first monograph in Poland devoted to project management maturity of organisations. Certified project manager in project (PRINCE2® and AgilePM®), portfolio (MoP®) and risk (M_o_R®) management. Member of PMI, IPMA and co-founder of the Association of Project Managers – Graduates of Postgraduate Studies in Project Management at the Warsaw School of Economics. top

Grzegorz Juszczyk | Poland | 2018 2019

Doctor of medical science, Director of National Institute of Public Health – National Institute of Hygiene. Since 2003 he is the scientist at Public Health Department at Warsaw Medical University. He co-operated with Medicover and LUX MED Groups, where he was responsible for planning and implementing health-benefited activities at work place. In LUX MED Group he leaded Health Education Office. He represented the Polish employers at the Advisory Committee of European Commission in relation to Health and Safety at work place. top

Katarzyna Anna Kacperczyk | Poland | 2024 |

Long-time government official. She has experience in international cooperation and support for economic and investment cooperation. Graduate of the University of Warsaw, Institute of International Relations and the prestigious Columbia University in New York (economics and management). She also studied at the European Institute (Legal Affairs Section) at the Saarland University in Germany and as part of the European Studies Programme – at the Warsaw School of Economics. For many years, Katarzyna Kacperczyk held prominent official and diplomatic positions at the Ministry of Foreign Affairs, including as the director of the Department of Economic Cooperation and Undersecretary of State (2013-2016) responsible for supporting the interests of the Polish economy and Polish businesses. In the years 2005-2008, she was a diplomat at the Permanent Representation of the Republic of Poland to the United Nations in New York, where she was responsible, among others, for issues regarding reforming of the Organisation. She served as advisor in the Chancellery of the Prime Minister. In 2018 she started working at the Warsaw School of Economics, where she was responsible for the development of international cooperation and supervised and led projects funded by national and EU funds. She was a lecturer at the Warsaw School of Economics, the National School of Public Administration and at the Lazarski University. In the years 2013-2015, she was a member of numerous government committees, including the Council of Ministers Committee for Digital Affairs, the Committee on Export Insurance Policy and the Investment Committee of strategic importance to the economy. She is a Centre for International Relations expert. Katarzyna Kacperczyk holds numerous awards and distinctions, including: Gold Cross of Merit (2012), Order of the Crown (Belgium) and class IV Order of Tomáš Garrigue Masaryk of the President of the Czech Republic. top

Rabia Kahveci | Ukraine | 2022

Rabia Kahveci is the Vice President of the HTAi, and Senior Technical Advisor for Pharmaceutical Policy and Governance in the SAFEMed project, in Kyiv Ukraine. SAFEMed project is a USAID funded and MSH led project that supports Ukrainian government. SAFEMed applies health system strengthening best practices to create evidence-based interventions and strengthen Ukraine’s pharmaceutical system. Her area of responsibility is to support priority setting and HTA, including and beyond capacity building and HTA institutionalization in Ukraine, as well as supporting pricing and reimbursement policies for health technologies. Besides her full time work at SAFEMed, she has been an active member of the HTAi for many years and served in the Board of Directors twice before being elected as the VP. During these years she chaired Annual Meeting Committee; co-chaired International Scientific Program Committee of HTAi Annual Meeting in Rome (2017); chaired Developing Countries Interest Group, co-chaired Medical Devices Interest Group; chaired the Organizing Committee of HTAi Regional Meeting hosted by Ukraine, in September 2020. She also chairs the Eurasian HTA Initiative that has members from 9 countries from Balkans and Central Asia. She acted as the President of the Turkish Evidence-Based Medicine Society for eight years. Prior to her position with SAFEMed, she was the director of a hospital-based HTA center in Turkey (ANHTA) that covered HTA, innovation for medical devices, and real-world evidence. She was a professor of family medicine in the same hospital. She contributed to several national and international projects around HTA, including EUnetHTA and AdHopHTA. ANHTA showed an impact of 2.5 million euros savings in 3 years, and stood as an outstanding example for HB-HTA at the global level. She served as the national clinical quality coordinator of the Turkish Ministry of Health in 2017, where she coordinated all activities involving HTA, clinical guidelines and quality. Prior to ANHTA, she served as a member of the Pharmaceuticals Reimbursement Committee of the Turkish Social Security Institution during the transition to universal health coverage and was a co-author of the reimbursement guidelines. She worked in the Turkish Medicines Agency on pricing and reimbursement of pharmaceuticals and led the HTA work of the Agency. Being an academic and medical doctor by background, with a degree in HTA, Prof. Kahveci authored over 150 peer-reviewed articles, 8 books and delivered over 300 presentations in international meetings on HTA. top

Ewa Kawiak-Jawor | Poland | 2022

Ewa Kawiak-Jawor graduated in sociology at the Maria Curie-Skłodowska University in Lublin. She obtained a PhD in health sciences at the Medical University in Lublin. She is also a practitioner specialising in qualitative and quantitative data analyses and new technologies in medicine and public health. Her scientific interests are focused mainly on e-health and m-health. Ewa Kawiak-Jawor is also a consultant in the field of healthcare organisation in international research projects. As a specialist in biostatistics, she supports the work of numerous research teams. She is an educator in the field of statistics and public health. top

Alastair Kent | UK | 2016

Alastair Kent came to Genetic Alliance UK over 20 years ago because he was excited by the challenge that new knowledge in genetics created - the idea that, for people affected by a genetic condition, yesterday’s science fiction is tomorrow’s clinical service improvement. Trying to transform these possibilities into positive outcomes whilst reducing the potential for abuse is an incredible challenge, and he feel incredibly privileged to work in this field. The fact that Genetic Alliance UK is now a respected and authoritative voice for patients and families is something about which he feel pride, and also a huge sense of responsibility. top

Paulina Kieszkowska-Knapik | Poland | 2017

Advises companies and industry organisations on healthcare law, especially the Pharmaceutical Law, the Reimbursement Act and the Act on Medical Activity. Paulina is also a co-founder of the Lege Pharmaciae Foundation, a non-governmental organisation formed to analyse and hold a public debate on defects in legal regulations in the healthcare sector. Paulina Kieszkowska-Knapik works with the Civic Legislation Forum at the Stefan Batory Foundation on the introduction of European lawmaking standards in Poland. Recommended for many years by Polish (Rzeczpospolita and Dziennik Gazeta Prawna) and international (Chambers Europe, PLC Which Lawyer) rankings as the best specialist in pharmaceutical law in Poland. She advises patient organisations pro bono, including the Polish Coalition of Cancer Patient Organisations, the Alivia Foundation and the Federation of Polish Patients. Paulina worked at Baker & McKenzie law firm for a decade, having previously worked at CMS Cameron McKenna. top

Miroslav Klugar | Czech Republic | 2017

Director of the Czech Republic (Middle European) Centre for Evidence-Based Healthcare: A Joanna Briggs institute Centre of Excellence and Assistant Professor at Department of Social Medicine and Public Health, Palacký University Olomouc, Czech Republic. He is also adjunct Associate Professor of Translational Health Sciences, at Faculty of Health Sciences, University of Adelaide, Australia and Co-Chair of European Joanna Briggs Collaboration. Miloslav is focused on the development, implementation, advocacy and teaching of Evidence-Based Healthcare, especially on the evidence synthesis. He is member of international method group of Joanna Briggs Institute, who developed methodology of systematic reviews of diagnostic test accuracy. As a member of JBI GRADE center, is Miloslav focused on the implementation and improvement of GRADE methods within systematic reviews and clinical practice guidelines, and as a member of ASPHER v4 Public Health group he is focused on the strengthening of Public Health competencies in V4 Public Health workforce through the Evidence-Based approaches and international collaboration. top

Katarzyna Kolasa | Poland | 2016

Katarzyna Kolasa, currently works as Senior Health Economics and Outcomes Research (HEOR) Director at GE. She has been working for healthcare sector for more than sixteen years now. She worked for AstraZeneca and BiogenIdec in both global and regional HEOR functions. At Bristol Myers Squibb and Lunbeck she was leading Market Access teams in CEE and Nordic Region. In the past she worked in Sweden, Switzerland and Finland. She holds a PhD degree in health economics and is an author of the number of publications in the field of health technology assessment and pharmacoeconomics. Katarzyna Kolasa is a reviewer for manuscripts submitted to Health Policy, Value in Health, Expert Review of Pharmacoeconomics & Outcomes Research and International Journal for Equity in Health. Her extensive knowledge in the field of health economics was acquired at University of York, University of Lund and University of Bergen as well as during International Doctoral Courses in Health Economics and Policy organized by the Swiss School of Public Health. Katarzyna Kolasa is DIA tutor for HTA courses, teacher at MBA in health program at Lazarski University, HTA training at Business School of Technical University in Warsaw and Adjunct at Nicolaus Copernicus University Collegium Medicum in Bydgoszcz. In addition to her role as a University teacher, she lead Equity study as a part of InterQuality project organized by Warsaw Medical University, funded under the European Union’s Seventh Framework Programme. She worked for World Bank regarding the hospital management project as well. Her practical skills in the field of health economics and insight into payers needs were developed during her six years employment contract at the Kalmar County Council in Sweden where she was responsible for a number of public health research programmes. top

Roman Kolek | Poland | 2020 2023 2024

Polish local government official, physician and activist of the German minority in Poland since 2010 to 2020, Deputy Marshal of the Opolskie Voivodeship. In the years 1999-2002, he was the director of the Department of Health and Social Policy of the Marshal’s Office of the Opolskie Voivodeship. In 2002, he was transferred to the position of Deputy Director for Medical Matters of the Regional Health Fund in Opole, and then took up a similar position in the Opole branch of the National Health Fund. He was also active in his community, participating in consultations regarding changes in the state health policy and the antibiotic therapy rationalisation programme. He was politically involved in the activity of the German minority in Poland within the Social and Cultural Association of Germans of Opole Silesia. In 2017, together with other German Minority members, he co-founded the “Regionalna. Mniejszość z Większością” (Regional. Minority with the Majority) party; in 2018 he became its deputy chairman. He taught classes at physician courses, as well as classes at the Pharmacoeconomics, Marketing and Pharmaceutical Law College at the Warsaw University of Technology. Roman Jacek Kolek has published scientific papers in the field of public health and health care finance, cost analyses of expenditure on health services provided to the insured, as well as lectures for physicians as part of training sessions and courses in public health and health insurance. He co-organised numerous conferences in the field of health policy and financing of health services, including the British-Polish Healthcare Forum, Polish-Ukrainian Healthcare Forum and the Polish-German Health Forum. He authored and co-authored numerous publications in the field of public health and financing of health services. In 2020, during the pandemic, he resigned from the position of Deputy Marshal of the Opolskie Voivodeship, returned to the profession of an anesthesiologist, currently he is the Deputy Director of the Provincial Hospital for healthcare, he is the Quality Representative. top

Martin Kolek | Czech Republic | 2018 2024

Medical Devices Market Access & HTA Lead Europe East and Israel at Organon. Experienced Market Access Executive with a passion for driving innovation and delivering results. Over 1000 projects completed, including designing and bringing new innovative products to market. He believes it is vital to add value, improve and find efficiencies in all you do. top

Konrad Korbiński | Poland | 2024

Konrad Korbiński is an advocate with many years of experience in the field of health care. He specialises in legal aspects of the organisation of the healthcare system, medical devices and processes of implementing innovative technologies to the healthcare system. For years, he has been providing legal, advisory, and expert services related to, among others, the pharmaceutical industry, medical devices, and healthcare entities. He was the head of the Political Cabinet of Minister Bartosz Arłukowicz and, in the years 2009-2011, he worked as an advisor to the Chancellery of the Prime Minister and later, as the head of the Political Cabinet of the Minister of Health participating in the legal amendments to the Act of Medical Activity and the Act on Reimbursement. top

Mariusz Kordecki | Poland | 2020

Expert and practitioner in the field of medical projects, CRO, EBM and HTA. He has many years of experience in the pharmaceutical sector and public institutions. Mariusz is the CEO at HTA Registry. He is the co-author of scientific publications, external lecturer at the Medical Collage of the Jagiellonian University (CMUJ), clinical expert for TUV NORD and an active trainer. He graduated from the Institute of Public Health at the CMUJ in Cracow. top

Anna Kordecka | Poland | 2016 2017 2018

Expert in health technology assessment and health economics. For ten years she has been specialising in quality assessment (audits) of analyses included in HTA reports. Author and co-author of systemic studies in healthcare and scoping aiming at determining the directions and scope of analyses required for reimbursement and pricing purposes. Partner in HTA Audit and HTA Registry. Active instructor in the fields of EBM, HTA and Pricing in public institutions and the pharmaceutical industry. top

Dorota Korycińska | Poland | 2020

Dorota Korycińska is a social psychologist. She has been actively helping patients and families struggling with rare diseases, as well as patients with disabilities for 20 years. She is the co-founder and, since 2009, the President of the Management Board of the Neurofibromatosis Association Poland (formerly the Association of Patients with Von Recklinghausen’s Disease and Other Phakomatoses). For years, she has ceaselessly worked to provide systemic healthcare to patients with neurofibromatosis. She is the President of the Management Board of the Polish National Oncological Federation. top

Anna Kostera-Pruszczyk | Poland | 2021

Professor Anna Kostera-Pruszczyk, MD, PhD, is a specialist in the field of neurology and child neurology, the Head of the Department of Neurology at the Medical University of Warsaw, which is a part of the European Reference Network on Rare Neuromuscular Diseases (ERN-NMD). She was awarded the title of professor of medicine in 2016. Professor Anna Kostera-Pruszczyk MD, PhD, specialises in the field of neuromuscular diseases. In terms of scientific interests and clinical work, her particular focus is on acquired and hereditary peripheral nervous system diseases, including spinal muscular atrophy (SMA). She acts as Vice-Chair of the Main Board of the Polish Society of Child Neurologists. Moreover, she is a member of the Expert Panel of the European Academy of Neurology for Neuromuscular diseases and a member of the Central Board of the Polish Neurological Society and numerous other scientific societies, both domestic and foreign. She is the author and co-author of publications with a cumulative Impact Factor of over 360. top

Katarzyna Kotulska-Jóźwiak | Poland | 2020 2021

Professor of neurology and paediatric neurology, Head of the Neurology and Epileptology Clinic at the Children’s Memorial Health Institute, Vice-Chairman of the Scientific Council at the Children’s Memorial Health Institute (CMHI) in Warsaw which is Poland’s reference paediatric hospital. Polish representative to the Board of EU Member States for European Reference Networks, vice-chair of the team on rare diseases, Head of the team coordinating the programme for treatment of spinal muscular atrophy. Member of the MAB BrainCity Scientific Committee. Graduate of the Medical University of Silesia, she conducts research in the field of developmental neurology, especially in the field of epileptogenesis and skin and nerve diseases. In the past, Katarzyna Kotulska-Jóźwiak was head and executor of several national and international grants. Author of over 150 peer-reviewed articles published in scientific journals.  top

Oskar Kowalski | Poland | 2020

Dr hab. n. med. Oskar Kowalski, professor and graduate of the Medical University of Silesia in Katowice. He currently works as a professor of the Medical University of Silesia in the Department of Human Nutrition at the Faculty of Health Sciences in Bytom. Furthermore, he has been Head of the Laboratory of Electrophysiology and Electrostimulation at the Silesian Centre for Heart Diseases in Zabrze since 2003. Prof. dr hab. n. med. Oskar Kowalski, Professor of the Medical University of Silesia, is an active member of the European Society of Cardiology. He is the Treasurer of the Executive Board of the Polish Society of Cardiology. Prof. dr hab. n. med. Oskar Kowalski, Professor of the Medical University of Silesia, is a Consultant at the Agency for Health Technology Assessment and Tariff System. He actively participates in research projects. He has won numerous Rector's awards in the field of scientific activity. Since 01/09/2020, he has been the Vice-Rector for Postgraduate Education at the Medical University of Silesia in Katowice. top

Maciej Krawczyk | Poland | 2020 2021

President of the Polish Council of Physiotherapists. PhD in medical sciences, PhD in Physical Culture in Rehabilitation, physiotherapy specialist. Graduate of the Faculty of Rehabilitation of the Józef Piłsudski University of Physical Education and an academic teacher at the university for 30 years. Employee of the Second Department of Neurology of the Institute of Neurology with the first stroke unit in Poland. Researcher and member of the Scientific Council at the Institute of Psychiatry and Neurology. Co-author of the Act on the physiotherapist profession. He specialises in the physiotherapy of patients who suffered damage to the central nervous system. Maciej Krawczyk has been the President of the National Council of Physiotherapists since 28 December 2016. He coordinates the work of the Polish Council of Physiotherapists which executes the tasks determined by the 1st National Congress of Physiotherapists; he supervises the work of the Polish Chamber of Physiotherapists Office, he represents the Polish Chamber of Physiotherapists before external entities (among others, state institutions). top

Zbigniew J. Król | Poland | 2017 2018

Undersecretary of State at the Ministry of Health in 2017–2019. Former Deputy director of the Agency for Medical Technology Assessment and an adjunct professor at the Institute of Public Health of the Jagiellonian University. From 2009 to 2011 he was on the board of Pfizer Polska sp. Z oo. Then he was the director of the Drawski Specialist Center (2012-2013) and the Specialist Hospital. S. Żeromski SPZOZ in Cracow (2013-2016). Undersecretary of State at the Ministry of Health. He is an honorary member of the College of Family Physicians in Poland. In his account he has, among others. Delegation of the Baltic Sea Task Force (later Northern Diamension) Experts Group for Primary Health Care and EQUIP - European quality workshop group. He was also an expert on the World Health Organization and the World Health Organization, as well as the project manager for the Data for Decision Makers project (Harvard-Jagiellonian Consortium for Health). top

Dušan Krstić | Czech Republic | 2018

Regional Sales Manager at EBSCO Information Services, a graduate of the University of Kragujevac (Serbia) with post graduate studies in Microbiology and Molecular Oncology at Masaryk University (Czech Republic). Since 2008, he was working is the medical field, specializing in technologies for Dermatology, Rehabilitation and Oncology. From 2017, he is managing Medical and Corporate market in Central and North-east Europe and CIS Countries, in EBSCO Information Services – world’s leading aggregator of medical and scientific literature. His primary aim is to provide access to evidence based medical information and primary medical, scientific and business literature to healthcare development organizations, healthcare professionals and companies operating in any field of healthcare for improvement of healthcare services, medical technologies and medical products development, assessment and vigilance. top

Anna Kupiecka | Poland | 2018

The chairperson of the Onkocafe Foundation. She was diagnosed with breast cancer in 2010. She is currently involved in wide-spreading the ideas of interpatient support and improving the quality of treatment and life of cancer patients. She is the founder and chairperson of the Onkocafe Foundation which aims to help patients and their families manage their anxiety, especially at the onset of the disease (directly after the diagnosis), as well as during the therapy and after the conclusion of cancer treatment. She is an author of manuals for patients and their families. She hosts a programme entitled "O raku przy kawie" (Let’s talk about cancer) on Radio RPLFM. top

Brygida Kwiatkowska | Poland | 2018 2020 2021 2022 2024

Professor Brygida Kwiatkowska is a rheumatologist; she was acting Clinical Affairs Director of the National Geriatrics, Rheumatology and Rehabilitation Institute (NIGRiR) in Warsaw since February 2013 and Deputy Clinical Affairs Director since 2018. In 2009, Prof. Kwiatkowska became acting Head of the Department of Early Arthritis Diagnosis of the Rheumatology Institute. She has been the Head of the Clinic of Early Arthritis as an Associate Professor in 2012. Moreover, she has been a member of the Scientific Council of the Rheumatology Institute for 14 years. In the years 2015-2017, she was the President of the NIGRiR Scientific Council. President of the National Rheumatology Council, she worked as the President of the Warsaw Division of the Polish Society for Rheumatology for 7 years; currently she is the Deputy President. Professor Brygida Kwiatkowska has been the National Consultant in the field of rheumatology since May 2021. She is also the President of the Polish Society of Autoimmune Diseases. Her research interests include diagnostics and treatment of rheumatic diseases. She conducts her work multidirectionally, by expanding the knowledge from other fields of medicine related to rheumatic diseases. Prof. Kwiatkowska promotes the use of new diagnostic techniques for diagnosing rheumatic diseases; she introduces state-of-the-art therapeutic methods. Her scientific contribution includes 52 publications. She is the lead author of most of them, meaning she is the key person responsible for the subject concept, processing of the results and preparation for print. top

Miranda W. Langendam | Netherlands | 2022

Dr Miranda Langendam is an epidemiologist with a background in health sciences and a keen interest in evidence-based health care. After her PhD in infectious diseases epidemiology she worked as senior researcher at the Dutch National Health Care Institute and senior staff member of Cochrane Netherlands. Currently she is an assistant professor and principle investigator at the department of Epidemiology and Data Science of the Amsterdam Medical Centers (University of Amsterdam). The focus of her research and teaching is evidence synthesis methodology, in particular guideline development and implementation. Her research line covers a broad spectrum of projects: from developing core outcome sets and risk of bias instruments to evaluation of guideline implementation and development of methodological frameworks. As methodologist she contributed to numerous guidelines on a variety of topics, for example for WHO and the European Commission. She is a board member of the GRADE working group, co-chair of the Dutch GRADE network and an active member of GIN and Cochrane. top

Ewa Lech-Marańda | Poland | 2023

Professor Ewa Lech-Marańda specialises in internal diseases, haematology, clinical transplantology and clinical immunology. She is the author of over 130 original works, review works and textbook chapters. In the years 1995-2010 she was an assistant and adjunct at the Department of Haematology of the Medical University of Łódź. In 2010, she started working at the Institute of Haematology and Transfusion Medicine in Warsaw as the deputy head of the Haematology Clinic. In the years 2015-2017, she served as the deputy Director for Therapeutics at the Institute, and in 2017 she was appointed by the Minister of Health as the Director of the Institute of Haematology and Transfusion Medicine. Since 2013, she has also been the head of the Haematology and Transfusion Medicine Clinic at the Centre of Postgraduate Medical Education in Warsaw and the voivodeship consultant in the field of haematology for the Masovian Voivodeship; what is more, since 2018, she has been working as the national consultant in the field of haematology. top

Line Helen Linstad | Norway | 2020

Line Helen Linstad, has worked at the Norwegian Centre for E-Health Research since 2002. She obtained a master in Political Science from the University of Oslo in 1994. She has also taken a part of a master programme in Management at the Norwegian Business School (BI), project management courses at BI Tromsø and internal management courses at the University Hospital of Northern Noway (UNN). She has experience in management and project management. She is a member of the HIMSS Europe Governing Council for the period 2015-2017. She has served on the EHTEL Board of Directors for two terms from 2011 - 2015. She is also advisor to the Barcelona Mobile World mHealth Centre. She has recently started phd in e-health. She previously worked as a health planner for the Regional Health and Social Care Board in the Northern Norway Regional Health Authority and as researcher in the Norwegian Federation of Organizations of Disabled People (FFO). top

Maria Libura | Poland | 2016 2017 2018 2019 2020 2021 2022 2023 2024

Head of Medical Training and Simulation Centre, University of Warmia and Mazury in Olsztyn, vice-President of The Polish Society for Medical Communication, healthcare expert of the Jagiellonian Club Analytical Centre, President of Polish Prader–Willi Syndrome Association. Member of the Expert Board to the Patients Ombudsman.  top

Krzysztof Łanda | Poland | 2017 2021 2022

President of MedInvest Scanner. Krzysztof was Deputy Minister of Health in 2015-2017 and was responsible for drug policy, reimbursement and prices of medical devices, mapping of health needs, investments in health care, prices of health services and the basic benefits package. Krzysztof was previously the CEO of HTA Audit, a company dealing with the quality assessment of HTA reports addressed to authorities and public institutions and the President of the Watch Health Care Foundation. In 2010-2011 he was President of the Central & Eastern European Society of Technology Assessment in Health Care. In 2006-2007 was a Director of the Drug Policy Department in the Central Office of the National Health Fund. In 2004 Krzysztof was elected to the Board of Directors of Health Technology Assessment International (HTAi) where he remained until mid-2007. In 2010-2012 and in 2006-2008 Krzysztof led capacity building in HTA in Ukraine and in Serbia. He was a team leader of a World Bank project aimed at introducing EBHC principles in Serbia.  top

Joanna Łapa | Poland | 2019

Team Leader at HTA Registry. Before taking this position, she was a project coordinator at CEESTAHC and an analyst at MedInvest Scanner as well as the Watch Health Care Foundation. She graduated from Public Health and Administration studies. top

Adam Maciejczyk | Poland | 2020 2022

Oncologist, specialist in oncological radiotherapy and director of the Lower Silesian Oncology Centre, head of the Radiotherapy Clinical of the Wrocław Medical University, president of the Polish Oncological Society and president of the National Association of Public Centres and Oncological Institutes. He specialises in childhood cancer treatment. He is a member of the Main Board of the Polish Society of Oncological Radiotherapy (PTRO), as well as the coordinator of the Paediatric Radiotherapy Section in the Polish Paediatric Group for Solid Tumours. Doctor Maciejczyk is also a member of the Therapeutic Radiology and Oncology (ESTRO) and the Paediatric Radiation Oncology Society (PROS). He is a member of the National Council for Oncology on behalf of the Polish Oncological Society, the Scientific Council of the Oncology Centre at the Marie Skłodowska-Curie Institute in Warsaw and the Transparency Council of the Agency for Health Technology Assessment and Tariffs. In 2019, he was appointed by the Minister of Health to participate in the work of the National Oncological Strategy Development Team. He is also an academic teacher. In 2019, he co-authored many papers and summaries, including, among others, publications like “The effect of YAP expression in tumor cells and tumor stroma on the prognosis of patients with squamous cell carcinoma of the oral cavity floor and oral surface of the tongue” or „The effect of the population-based cervical cancer screening program on 5-year survival in cervical cancer patients in Lower Silesia”. top

Kamila Malinowska | Poland | 2016

Deputy Director of Drug Policy And Pharmacy Department in the Ministry of Health, former Head of Analysis and Strategy Division in the Agency for HTA and Tariff System, Chief Expert in the National Health Fund (NHF) and Specialist in HTA Consulting. top

Maciej Małecki | Poland | 2018

He graduated from the Faculty of Medicine of the Nicolaus Copernicus Medical Academy in Cracow in 1988. Specialist in internal medicine, diabetology, laboratory diagnostics and endocrinology. In 1998, he defended his PhD thesis entitled "Searching for genes predisposing to type 2 diabetes in chromosome 20q" with honours at the Jagiellonian University Medical College. The thesis was awarded the Aurelia Baczko Award from the Polish Foundation for the Promotion of Science of the Society for Supporting Sciences for the best doctoral dissertation in the field of non-surgical clinical medicine. In 2004, he received a postdoctoral degree after submitting his dissertation entitled "Molecular basis of type 2 diabetes – selected pathogenetic and clinical issues". In 2009, he received the Professor title. Between 1993 and 2000, he worked as an assistant at the Department of Metabolic Diseases of the Jagiellonian University Medical College; in 2000, he became an adjunct there; in 2008 he became the dean of the department – as an associate professor since 2009 and, since 2013, as a professor of the Jagiellonian University. Between the years 1996 and 1999 he was a scholar at the Joslin Diabetes Center in Boston, affiliated with the Harvard Medical School. His scientific interests include the genetic background of monogenic and type 2 diabetes, as well as clinical research in diabetes, especially related to pregnancy. He is the author and co-author of around 180 scientific articles, including 150 original works; his works have been quoted over 3000 times until the year 2017 (IF of about 600, 26 in the Hirsch index). He has been a member of the General Board of the Polish Diabetes Association (since 2007) and the President of the Association since 2015. He was a board member of the European Society of Clinical Investigation. He is a member of the European Association for the Study of Diabetes, and an EASD expert on etiological diabetes. He participates in the works of the EASD Study Group on the Genetics of Diabetes. In 2001, he received an award from the Polish Diabetes Association for his achievements in the field of diabetology, and in 2005, he was invited to give a lecture under the auspices of Jakub Węgierko during the Polish Diabetes Association Conference. For his outstanding scientifical achievements, he was recognised with an award of the Prime Minister (2006) and also received a team award from the Minister of Health (2009). In 2013, he received a Browicz Award from the Polish Academy of Learning, and in 2014 he received a Jagiellonian Laurel and a Śniadecki Award from the Polish Academy of Sciences. He has been a member of the Polish Academy of Learning since 2017. He is a reviewer in Endocrine Review, Diabetes, Diabetes Care, Diabetologia, Diabetic Medicine and several Polish journals and also an editor in the European Journal of Clinical Investigation and Diabetologia Praktyczna. He is an EU expert in the evaluation of scientific projects within the FP6, FP7 and Ideas programmes. He has published articles in world-leading scientific journals, including Nature Genetics, Nature Clinical Practice Neurology, New England Journal of Medicine, Diabetes, Diabetologia, Diabetes Care, Stroke, Neurology and others. Between the years 2008 and 2012, he was a deputy dean for organisation and curriculum at the Faculty of Medicine of the Jagiellonian University Medical College; between 2012 and 2016 he was the Jagiellonian University dean's proxy for research and development at the Jagiellonian University Medical College. Since 2016, he has been the Dean of the Faculty of Medicine of the Jagiellonian University Medical College. top

Monika Małowicka | Poland | 2022

Specialist in the field of EBM. She has been involved with the Clinical Analyses Department of HTA Consulting based in Cracow for 8 years; currently she is a Lead Project Manager there; this position ensures diversity and allows for a wide scope of activities. CEESTAHC lecturer. Co-author of numerous HTA publications and reports on current systematic solutions adopted in health care in Poland and across Europe. Monika Małowicka graduated in molecular biology at the Adam Mickiewicz University in Poznań and completed postgraduate studies in pharmaceutical marketing (Medical University of Silesia) as well as in clinical trial methodology, organisation and management (Jagiellonian University). Privately, a dog lover, full of energy and optimistic about life. Walks, travels (even those with a finger on a map) and good food put her in a good mood and relax her. Apparently she cooks quite well herself. She is pushed forward by her openness and curiosity about the world, people and things. However, she found her refuge and place to breathe when she moved from the hustle and bustle of the city to a house in the countryside hidden behind a row of trees. top

Ileana Mardare | Romania | 2016

Currently, Senior Healthcare Consultant, both in public & private health related projects. Since 2015, Dr. Mardare is dedicated to medical education and personal development of the young professionals, as assistant professor in Public Health and Management Department, University of Medicine and Pharmacy „Carol Davila” Bucharest, Romania. Physician with both medical and Health Outcomes Research background, with a vast experience on healthcare and health system management. Along the 25 + years of activity, she had the opportunity to work and learn in various positions, at different levels - medical practitioner (Infectious Diseases Specialist), hospital manager, Medical Director of a County Health Insurance House, senior counsellor - Ministry of Health, Public policies Department and also in Pharma Industry - from Medical Representative to Senior Health Outcomes Manager/ Public Health Manager. As a result, she has a deep understanding of the Romanian Healthcare System in dynamics, from different perspectives, from big picture to tiny details that can make the difference. top

Edyta Masłowska-Parafian | Poland | 2024

Deputy CFO and COO at Łukasiewicz Research Network – ITECH Institute of Innovation and Technology. MSc in management with 20 years of experience in financial management and in shaping and implementing entities' financial strategies. As an expert on European Funds, Edyta Masłowska-Parafian has been involved in public administration, as well as acquisition, disbursement, and settlement of EU projects since 2004. She played a key role in setting up the management and financing system for projects implemented under European Funds in the Ministry of Regional Development. She was also involved in the control of projects co-financed by the European Social Fund implemented by non-governmental institutions, entrepreneurs, as well as local government units or Offices. Moreover, she worked at the Ministry of Labour and Social Policy, where she carried out over 200 on-site project inspections. Former Head of Selection and Monitoring Department of systemic projects implemented under the Human Capital Operational Programme, where she supervised the work related to acquisition, monitoring and settlement of projects implemented under the HCOP. She held the position of the Head of the Forecasting, Analysis and Monitoring Department at the Educational Research Institute which is tasked with the acquisition and implementation of projects co-financed by the EU Funds. What is more, she conducts specialised training courses on the acquisition of EU Funds as well as the management and control system for EU-funded projects, the use and settlement of EU Funds, including the system of financial flows and certification, the monitoring and reporting system, eligibility of expenditure, settlement of EU Funds. Author or co-author of a number of publications on the management and financing of EU Fund initiatives, as well as a number of procedures, management and control systems for those involved in the EU Funds implementation system. top

Piotr Merks | Poland | 2018

Piotr Merks, PhD (Pharmacy), is the chairman of Piktorex Sp. z o.o. and has over 16 years of experience in the pharmaceutical industry. He is an expert on the implementation of the Falsified Medicines Directive (FMD), innovative projects and designing new pharmaceutical services, a lecturer at the Nicolaus Copernicus University in Toruń and Collegium Medicum in Bydgoszcz, and a winner of many pharmaceutical awards in Poland and abroad. He has international experience in various sectors: research facilities, governmental and non-governmental bodies, commercial companies, hospitals, pharmacies. He has worked in the pharmaceutical industry in the UK for over 10 years. His career path has also led him to Australia, Canada and Finland, where he had the chance to learn about other pharmaceutical markets in practice. He belongs to many branch organisations, such as the British Royal Pharmaceutical Society (RPS), the International Pharmaceutical Federation (FIP), the European Association of Employed community Pharmacists in Europe (EPHEU), the British Pharmacists’ Defence Association (PDA). He is a member of the District Council of the Pharmaceutical Chamber of Warsaw and the Polish Pharmaceutical Chamber (the Department of Foreign Cooperation). He actively works to improve public health and the safety of medicines and to eliminate falsified medicines from retail trade. He is the inventor and the coordinator of the pharmaceutical tool Lekolepki. He is the author of various projects and publications, and a participant of international conferences. top

Piotr Miazga | Poland | 2018

Piotr graduated from the Jan Kochanowski University in Kielce and the Cracow University of Economics. He is a Market Access Consultant and the Director for Analytical Development in HTA Consulting. He specialises in financing health services, as well as in the field of local self-government health programmes. He is responsible for the development of institutional cooperation in Poland and CEE countries. top

Maciej Miłkowski | Poland | 2022 2023

Manager, graduated from the Warsaw School of Economics (SGH), as well as from the MBA studies at the Leon Kozminski Academy of Entrepreneurship and Management in Warsaw – Management and Economics of Medical Technologies. His first professional experience was in investment banking at Polski Bank Inwestycyjny (Polish Investment Bank). Since the beginning, i.e. since April 1998, Maciej Miłkowski was co-organising Mazowiecka Regionalna Kasa Chorych (the Mazovian Regional Health Care Fund) and became its first member of the management board for economic and administrative affairs, as well as its CFO. For 3 years, starting from 2002, he was head of a non-public health care institution of the European Rehabilitation Clinic VICTORIA. In the years 2005-2007 he worked in the Institute of Mother and Child as the representative of the director for financial and accounting affairs and as the deputy director for economic affairs. Between June 2007 and January 2016 Maciej Miłkowski worked as the deputy director for economic affairs of the Cardinal Stefan Wyszyński Institute of Cardiology in Warsaw. In 15 January 2016 he was appointed the Deputy President of the National Health Fund for Financial Affairs. He has been the Under-Secretary of State at the Ministry of Health since 2018. top

Magdalena Ruth Moshi | Australia | 2023

Magdalena Ruth Moshi, BHlthSc (Hons), PhD, OLY Dr Magdalena Ruth Moshi is a Senior Research Officer (SRO) at the Royal Australasian College of Surgeons (RACS). Her current role includes conducting health technology assessments as part of the Australian Safety and Efficacy Register of New Interventional Procedures-Surgical (ASERNIP- S) team. Magdalena’s research interests include developing health technology assessment methodologies that can address the unique challenges posed by innovative software or healthcare contexts. She has peer reviewed articles on the topic for the International Journal of Technology Assessment in Health Care.  top

Marta Musidłowska | Poland | 2023

Graduate of the Faculty of Law and Administration at the University of Warsaw, specializing in digital policies within European Union law. Analyst of Polish, EU and US regulations related to new technologies, primarily data governance in various sectors (mainly healthcare). She has gained practical experience in Polish and international law firms, as well as in policymaking in the United Nations and Polish public administration initiatives. At the end of July, she finished traineeship at DG SANTE in the European Commission, where she supported work on the European Health Data Space. Currently she is a legal researcher in the Center of IT and IP Law in the KU Leuven, where she works on a Data Spaces Support Centre project. She is also a journalist writing texts on new technologies, as well as digital & energy policy in the CEE region. top

Maciej Niewada | Poland | 2020

Clinical pharmacologist, neurologist; assistant professor at the Department of Experimental and Clinical Pharmacology at the Medical University of Warsaw. He graduated from the Faculty of Medicine at the Medical University of Warsaw in 1997. He concurrently studied at the Warsaw School of Economics, where he obtained a master’s degree in Economics in 2000. Since 1997, he has been working at the Department of Experimental and Clinical Pharmacology at the Medical University of Warsaw, where he obtained a specialisation in clinical pharmacology. He is a lecturer at the Business School of the Warsaw University of Technology and a specialist at the Therapy and Drug Science Committee of the 5th Faculty of Medical Sciences of the Polish Academy of Sciences. In the years 2000-2006, he was an assistant at the 2nd Neurological Clinic of the Institute of Psychiatry and Neurology. In 2004, he received a PhD in Medical Sciences (his doctoral dissertation concerned the costs of stroke from the social perspective), and in 2013, he was habilitated (based on his work regarding the Hospital Register of Strokes in Poland). Since 2009, he has been the CEO of HealthQuest – a consulting company operating in health technology assessment and reimbursement. He co-authored the health technology assessment guidelines adopted by the Agency for Health Technology Assessment, and also co-authored health technology assessment reports, costs analyses, epidemiological studies and studies concerning quality of life and utility. Maciej Niewada is also one of the founders of the Polish Pharmacoeconomics Society (ISPOR Poland Chapter), where he is currently the President. Furthermore, he cooperates with the Ministry of Health, the National Health Fund and medical scientific societies. His research interests include health technology assessment, pharmacoepidemiology and prevention of cerebrovascular diseases. top

Rafał Niżankowski | Poland | 2016

Professor Rafał Niżankowski, MD, PhD is a member of the European Working Group on Medical Angiology IUA. He is initiator of the angiology medical specialisation in Poland, co-founder of the Polish Angiology Society, creator and head of the Angiology Clinic of the Jagiellonian University. He is regional consultant on In the field of angiology and President Elect of the Polish Angiology Society. top

Tanja Novakovic | Serbia | 2016 2021

Tanja Novakovic MSc Pharm is director of ZEM Solutions Ltd and the president of the Pharmacoeconomics Section within the Pharmaceutical Association of Serbia. After finished postgraduate studies in Health Economics at Ghent University in Belgium she has made significant contributions to developing knowledge and experience in heath economics and HTA, organizing many international Conferences and bringing together world experts in this field. She is author of the “Handbook for pharmacoeconomic evaluations” (2006), the first publication in the field of pharmacoeconomics in the Serbian language, Serbian pharmacoeconomic guidelines (2011) and co-author of the book Health Economics (2014). Tanja participated in several projects in a wide range of fields, including: Big Data, disease areas such as oncology, rare diseases, nutrition, Rheumatology, biosimilars and has previously been involved in World Bank and Ministry of Health of Serbia projects. Tanja has organized and presented in many national meetings and international conferences which have resulted in international cooperation in education and the developing of pharmacoeconomics and HTA in Serbia. top

James O’Brien | Australia | 2020

A Chair, Director, Advisory Council Member and CEO in International Prader-Willi Syndrome Organisation (IPWSO) with over twenty years of board level experience across the public, commercial & not for profit sectors with particular experience in the construction, education and disability services industries. The president of the Prader-Willi Syndrome (Australia) where he has recently steered the amalgamation of State PWS Associations to a unified PWS Australia. Vice Chair of the International Prader-Willi Syndrome Organisation, enabling both Australian and global initiatives and research that have improved the lives of those living with PWS world wide; and Council Member of Global Genes RARE Global Advocacy Leadership Council, championing the needs and explored ways to establish and foster person and family support organisations in every syndrome in every country. Founding Director and CEO of PWS Better Living Foundation Ltd where he is exploring local housing development opportunities for individuals and families living with PWS. He is a Graduate of the Australian Institute of Company Directors' Company Directors Course, he hold a Commercial Real Estate License and a Graduate Diploma of Applied Finance. top

Daniel Ollendorf | USA | 2023

Dan Ollendorf is Director of Value Measurement and Global Health Initiatives at the Center for the Evaluation of Value and Risk in Health (CEVR). His research interests include expanding the use of health technology assessment in low- and middle-income economies, as well as refinement of value assessment tools in the US. Prior to joining CEVR, Dr. Ollendorf was Chief Scientific Officer for the Institute for Clinical and Economic Review (ICER) for over 10 years, where he was responsible for scientific oversight of all clinical and economic aspects of the health technology assessment process. Dr. Ollendorf holds a PhD in clinical epidemiology from the University of Amsterdam and an MPH from Boston University. He is the current Chair of the Health Technology Assessment International Global Policy Forum as well as a non-resident Fellow at the Center for Global Development, and served on the US Medicare Evidence Development and Coverage Advisory Committee (MEDCAC) from 2015-2019. Dr. Ollendorf has authored over 100 articles in peer-review journals and is co-author of The Right Price: A Value-Based Prescription for Drug Costs (Oxford University Press). top

Wija Oortwijn | Netherlands | 2018 2023

Wija Oortwijn is affiliated with Radboud University Medical Centre Nijmegen, Department for Health Evidence (the Netherlands). She studied health sciences and holds a PhD in Medicine (Priority setting for Health Technology Assessment - HTA). She has more than 25 years of relevant professional experience in HTA and health policy analysis. She led studies on mapping the level of HTA in countries around the globe and was involved in the research project INTEGRATE-HTA (www.integrate-hta.eu), aimed to develop concepts and methods to enable patient-centred, integrated assessments of the effectiveness, and the economic, social, cultural, and ethical issues of complex technologies that take context and implementation issues into account. Recently, she concluded a project on improving HTA and decision-making in 10 selected countries around the globe (published in Value in Health), and a project to describe the extent to which HTA is aligned with values and principles that underpin the health system in a selection of countries. Currently, she is developing a practical guide for HTA organizations regarding the implementation of ‘evidence-informed deliberative processes’ (EDPs). EDPs provide guidance to HTA organizations to improve their processes towards more legitimate decision-making. EDPs is based on rational decision-making through evidence-informed evaluation of identified values (as reflected in multi-criteria decision analyses - MCDA) as well as fair decision-making (as reflected in the accountability for reasonableness approach – A4R). She is a founding Member of the Dutch (NVTAG) and the International Society for HTA (HTAi), past Board Member of both societies and has been co-chair of the HTAi/INAHTA Interest Group on Ethics from 2011 until 2017. Currently, she is a member of the HTAi Scientific Development and Capacity Building Advisory Committee, co-chairing the International Working Group to update the definition of HTA, and is associate editor of the International Journal of Technology Assessment in Health Care. Furthermore, she is the scientific secretary of HTAi’s Global Policy Forum: for 2016-2017 (on value frameworks), for 2017-2018 (on horizon scanning) and for 2018-2019 (on real world evidence). top

Sylvia Atisa Opanga | Kenya | 2022

Sylvia Opanga is Clinical Pharmacist and a Senior Lecturer at the University of Nairobi’s School of Pharmacy. She holds a PhD in Clinical Pharmacy from the University of Nairobi. Her main areas of interest are Surgical, Cardiovascular and Infectious disease pharmacotherapy in which she has published extensively. She is currently guest editor for the Vaccines journal Special Issue 2022. She holds a fellowship in Implementation Science from the University of Washington, Seattle. She is also interested in evidence based research and clinical practice, and has worked on several systematic reviews and meta-analyses that have impacted policy, mostly on antibiotic use in Kenya is a member of the Ministry of health antimicrobial stewardship technical working group.Sylvia is dedicated to ensuring patient safety through proper medication use and use of big data in improving patient safety in Kenya and Africa as a whole. In this regard, she is the founding East African Lead for the International Society for Pharmacoepidemiology (ISPE) and the Medicines Research and Utilisation Group in Africa (MURIA). Sylvia has won two grants- the Newton Grant (2017-2019) and the Fleming Fund Kenya Grant on AMR Surveillance (2019-2021), both of which have done extensive work in curbing antimicrobial resistance. In March 2021, she was awarded a grant to attend the Uppsala Health Summit that focused on behaviour change to combat antimicrobial resistance. She has subsequently won the Institut Merieux Young Investigator Award for her work in COVID 19 and implementing the National Action Plan on antimicrobial resistance in Kenya. Her innovation in diabetes care won the best innovation at the Nairobi Innovation Week in 2022. top

Mark Parker | Serbia | 2022 2023

Mark Parker is director at ZEM Solutions with more than 20 years experience in international health economics projects and health technology assessment. He is Health Economic modeller (University of Liverpool, University of York, UK) and Health Economics Consultant. Primarily involved in leading the development of care pathways, economic models and their evidence basis for use in global value dossiers, international HTA submissions, and national projects such as DRG development, patient registries and their analysis. Further specialising in the challenges of the CEE region and healthcare development. Mark has experience in a wide range of disease areas and population modelling, he is working with industry, NGOs and governmental institutions to deliver a strong educational background in economics, software development, distributed systems and computation, Artificial Intelligence (1st, BSc Economics and Computer Science, UoL). top

Bonny Parkinson | Australia | 2023

Associate Professor Bonny Parkinson is the Interim Deputy Director and a health economist at the Macquarie University Centre for the Health Economy (2022). She has also worked at the University of Technology Sydney, AstraZeneca in the United Kingdom, Access Economics, and the Australian National University. She currently co-leads a team of researchers conducting evaluations of submissions to the Pharmaceutical Benefits Advisory Committee (PBAC) and researching economic evaluation methodology. She has been involved in over 50 evaluations of submissions to the PBAC since 2009, and has also conducted evaluations of submissions to the Medical Services Advisory Committee (MSAC). To date, she has been the recipient of career research funding of over $22.0 million spread over 16 grants and has 38 peer-reviewed journal articles. She is currently on the editorial board of Pharmacoeconomics, and is an associate editor of Oxford Open Economics. top

Joanna Parkitna | Poland | 2024

Joanna Parkitna - Director of the Health Technology Assessment Department, Agency for Health Technology Assessment and Tariff System. top

Chris L. Pashos | USA | 2021

Dr. Pashos serves on the Board of Directors, and is Chief Medical Officer and Head of Research Partnerships, of Genesis Research, an international consultancy supporting the life sciences industry.  Genesis Research is known for its unique partnership model through which it provides evidence-based, technology-enabled and scientifically rigorous solutions across all aspects of value demonstration.  Besides his work in consulting, Dr. Pashos's career has spanned periods in academia (Harvard Medical School) and life sciences companies (Takeda and AbbVie). A Charter Member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Dr. Pashos served as ISPOR President in 2008-2009.  top

Marcin Pasiarski | Poland | 2023

Specialist in internal medicine, haematology and immunology. Professor and lecturer at the Faculty of Medicine and Health Science of Jan Kochanowski University in Kielce. Since 2015, he has held the position of the Voivodship Consultant in Haematology. He graduated from the Medical University of Lublin (where he also obtained his doctorate in medical sciences in 2009). Since 2001, he has been working at the Holy Cross Cancer Centre in Kielce. Since 2011, he has been in charge of the haematology unit and, since 2014, of the Department of Haematology and Bone Marrow Transplantation at the Holy Cross Cancer Centre. Scientific research on the assessment of the effectiveness of vaccination against Streptococcus pneumoniae (pneumonia ducta) in patients with chronic lymphocytic leukaemia and monoclonal gammopathy of undetermined significance has been carried out under the supervision of Professor Pasiarski. Based on his research, he developed the first pneumococcal vaccination programme in Poland and Europe for oncological patients, offering them protection against pneumococcal pneumonia and sepsis. top

Marta Pawłowska | Poland | 2024

Expert in health promotion and disease prevention, in particular overweight prevention and systemic solutions to reduce obesity in children and families. She has a knowledge in this area and is gaining unique experience on the international market. Marta Pawłowska is also a strategy and health education projects specialist, consultant to businesses, NGOs, and local government administration. Moreover, she is the Co-founder and President of the Presidium of the Partnership for the Prevention and Treatment of Obesity, initiator and co-author of the strategic assumptions of the national plan for reducing obesity in Poland. She has 25 years of experience in managing health, social, and educational campaigns, implemented in Poland and abroad, as well as in crisis communication. In years 2019-2021, she acted as the Director of the Health Prevention Bureau (Biuro Profilaktyki Zdrowotnej) of the Central Office of National Health Fund. Graduate of the MBA Oxford Brooks University and MBA in Health Care at the Lazarski University. Author of health publications, family health specialist with 10 years of expertise in eating disorders and compulsive behaviours, narrative therapist in the certification process at the Dulwich Centre in Australia. top

Serhii Pekh | Ukraine | 2023

Serhii Pekh is a unique influencer whose activities on social media have meaningful impact on society. His main goal is to make the rules of legal residence in Poland and procedures for entering Poland more commonly known, not only for Ukrainian citizens, but also for other nationalities. As a community activist, Serhii is a co-founder of Wellcome EU foundation, which aims to help refugees from various countries in difficult times. Serhii Pekh is not only an influencer, but also a philanthropist. His involvement in helping refugees of various nationalities shows that he always puts humanitarian matters first. Moreover, as an investor, he’s aware of the role that business can play in creating positive social changes. His versatility and psychological knowledge help him understand how social media works and what is the best way of conveying his social messages. Serhii Pekh is an individual who inspires and motivates others to work for the common good and understands the needs of refugees and migrants in Poland, regardless of their country of origin. top

Barbara Pepke | Poland | 2023

President of Gwiazda Nadziei Foundation. Leader of the Hepatology Coalition. She is a campaigner for patients suffering from liver diseases. Barbara is a former hepatitis C patient herself. What is more, she has co-founded the Gwiazda Nadziei Foundation and has been its President for over 15 years. When it comes to her professional life, Barbara has been associated with the local government for over 25 years, and currently with the voivodship government. She is a Councilwoman of the Mikołajów County for the 5th Term, and currently the Chairwoman of the Mikołajów County for the 6th Term. She has initiated numerous social campaigns, trainings and educational programmes in the field of liver disease and cancer prevention. Moreover, she co-created numerous educational campaigns directed at young people, teachers, residents, physicians and, lately, also Ukrainian refugees. Barbara is the originator, co-author and coordinator of the publications published by the Gwiazda Nadziei Foundation, used in campaigns promoting free tests and educating GPs and teachers on the current knowledge about hepatotropic virus infections. She strongly believes that health and human life are of paramount value. top

Janina Petelczyc | Poland | 2024

Social security expert specialising in particular in pension systems, ESG funds, and international comparative social policy. Since 2020, she has been a member of the Occupational Pensions Stakeholder Group of the European Insurance and Occupational Pensions Authority. Her scientific interests primarily include social security. top

Elena Petelos | Netherlands / Greece | 2021 2024

Elena Petelos is a Senior Research Fellow in Public Health and a Lecturer in Evidence-Based Medicine and Evidence-Informed Policy at the University of Crete (Greece) and at Maastricht University (The Netherlands). She also teaches at Charité-Universitätsmedizin Berlin (Germany) and is Adjunct Faculty at the newly founded University of West Attica (Greece). She has a background in medicine and biology, specialising in molecular oncology, and re-training mid-career in health economics and policy, continuing with a Fellowship in Governance and Economics of Development Technology and Innovation at the United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology. She currently also serves as the Vice President of the Health Technology Assessment section, a Member of the Steering Committee of the Law and Public Health Section, a Member of the Infectious Disease Control section, and the Chair of the Gender Equality Working Group (SDG5 WG) at the European Public Health Association. She is the Co-Chair for Real-World Evidence and Artificial Intelligence at HTAi, a Member of the Healthcare Professional’s Working Party of the European Medicines Agency (EMA) and a Member of the Advisory Forum of the Health Emergency Preparedness and Response (HERA) of the European Commission. She is a Member of the Advisory Board of the European Forum for Primary Care leading the Vaccines WG and representing it in the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP). She also serves in ENCEPP’s WG2 on Transparency and Independent Research. Her research, policy and advocacy work focuses on international collaboration, including regulatory frameworks and legislative frameworks, to improve global health and towards achieving digital equity and reaching UHC, with special emphasis on real-world evidence, benefit/risk communication, new technologies, and artificial intelligence. She is also a member of the Royal Netherlands Society of International Law (KNVIR) and of the International Law Association (ILA). top

Ozren Pezo | Croatia | 2021

Independent business and ICT expert, World Bank and EC consultant,  member of Supervisory Board of “HL7 organization Croatia”. Ozren Pezo graduated Computer Science and Diploma in Management of University of Zagreb and hold Master in IT from Politecnico Milano. Mr. Pezo worked as CIO in the Croatian Health Insurance Fund (CHIF) from 2014-2017. During that period, he was holding the following responsibilities and duties: Chairman of Governing Council of Croatian Institute of Telemedicine, Member of National Committee for IT Strategy of Healthcare, National contributor at European Cloud in Health Advisory Council. Mr. Pezo was responsible for strategic planning, development and operational excellence of IT in CHIF and Croatian national e-Health projects. (ePrescription, eReferral, eBooking, eSchedule Li eFindings, BI portal, Fraud detection tool, eCitizen health portal, EHR, etc.). Previously he worked on various management position on several ICT companies in SEE region including 9 years for Microsoft. The last 4 years working as an international ICT and business expert and consultant for World Bank, European Commission on various healthcare reform projects in Asia, Africa and Europe. His expertise includes national eHealth strategy and development and implementation of eHealth systems, health insurance process optimizations, health insurance information systems, fraud detection and preventions in healthcare system. Speaker, presenter and panelist at more than 15 national, region and international IT/Health conferences. top

Maria Piętak-Frączek | Poland | 2020 2021 2022 2023 2024

She has been working at the Cracow City Hall for 20 years, since 1999. She graduated from the Nursing Institute at the Faculty of Healthcare of the Jagiellonian University Medical College. In 1997, she completed post-graduate studies in Health Promotion at the Institute of Public Health of the Jagiellonian University. In 2012, she completed post-graduate studies in Economy and Public Administration at the Małopolska School of Public Administration of the Cracow University of Economics. In 2019, she completed post-graduate studies in HTA and EBM in Healthcare Management as part of the “Development of administrative and management competences for quality improvement in healthcare” project organised by the Faculty of Health Sciences of the Jagiellonian University. From the beginning of her work, she has been developing the principles of the “Healthy Cracow” Municipal Healthcare Programme, organising conferences, trainings and outdoor health-related events, including the “Cracow Health Days”. She cooperates with numerous regional and national healthcare-related institutions. She is also a representative of the City of Cracow in the Association of Healthy Polish Cities and the President of the Management Board of the Association. As part of this activity, among others, she organises meetings for member cities which address significant issues regarding healthcare and prevention. Healthcare manager - completed postgraduate studies in 2022: Healthcare management. top

Vinciane Pirard | Belgium | 2017

Vinciane is director of public affairs at SANOFI where she is responsible for rare diseases and specialty care. She has collaborated to IMI ADAPT-SMART work package 3. She is the co-chair of the European joint industry task force on rare diseases and orphan medicinal products. (A joint task force between European Federation of Pharmaceutical Industries and Associations (EFPIA) and the European Association of Bioindustries (EuropaBIo)). Previously she worked 8 years at Genzyme medical department on diagnosis, registries and product development for rare genetic diseases. She also worked at Solvay Pharma and Wyeth. top

Robert Plisko | Poland | 2017 2018 2019 2020 2021 2022 2023 2024

Robert Plisko is CEO at HTA Consulting since 2006 and one of the company’s founders. He obtained his Master of Economics title at the Cracow University of Economics. His professional career started at the National Centre for Quality Assessment in Healthcare. Robert Plisko is the author of numerous publications on HTA and health care. He is head of the Economic Analyses Department at HTA Consulting. top

Marta Podhorecka | Poland | 2024

Prof. Marta Podhorecka is a physiotherapist, specialist in health promotion and health education, creator and implementer of projects dedicated to senior citizens, professor at the Department of Geriatrics of Collegium Medicum Nicolaus Copernicus University, President of the Senior Citizen Policy Council at the Ministry for Senior Policy. She is a member of the Bydgoszcz Equal Treatment Council, International Association of Gerontology, vice-president of the Kujawsko-Pomorskie branch of the Polish Society of Gerontology and a member of the Polish Physiotherapy Association Management Board. In recognition of her popularisation activities and research for the benefit of senior citizens, and in particular her initiatives to counteract discrimination against senior citizens and promote intergenerational integration, she was awarded the first title of Senior Citizen Supporter” (“Przyjaciel Seniora”) in 2019 by the Jolanta Kwasniewska Foundation “Communication without Barriers”. top

Tadeusz Popiela | Poland | 2018

Head of the Department of Diagnostic Imaging of the Emergency and Mass-Event Medicine Trauma Centre of the University Hospital in Cracow, and associate professor of the Department of Radiology at the Medical Faculty of the Jagiellonian University Medical College. Graduate of the Jagiellonian University Medical College. In 2000 he was the first person in Poland to perform a thick-needle, vacuum-assisted breast biopsy, controlled by both digital mammography and ultrasound. His experience in this type of procedures has been presented in a paper awarded during the Cardiovascular and Interventional Radiological Society of Europe symposium in 2001 in Göteborg. He was the first organiser of the Polish edition of the IBUS (International Breast Ultrasound School) seminar in 2006, the title of which was “Diagnostic Imaging of Breast”. He has been involved in research related to testing of an innovative device for contact thermography based on the technology of passive liquid-crystal matrices since 2013. He created and edited the first Polish Thermographic Atlas of Breast Cancer issued by the Polish medical publishing house PZWL in 2015. He is the author of over 100 published papers, 92 presentations at foreign conferences and 133 national conferences. He has completed 4 national and 2 foreign grants and 11 statutory projects covering issues of both breast glands invasive oncological diagnostics as well as interventional radiology methods. He is a representative of the Polish Medical Society of Radiology. He is also a reviewer at the following journals: Journal of Radiology, Polish Journal of Radiology and Medycyna Praktyczna. In 2018, professor Tadeusz Popiela, together with professor Agnieszka Słowik, received the Prime Minister's award for organising and coordinating a system of causative treatment of ischemic stroke via mechanical thrombectomy (CITO), addressed to the residents of Małopolska. 200 patients were treated using this system. top

Maarten J. Postma | Netherlands | 2021

Maarten J. Postma holds the chair Global Health Economics at the University Medical Center Groningen (UMCG) and the faculty of Economics & Business, both at the University of Groningen and is director of UMCG’s research institute SHARE. He is also a professor in Pharmacoeconomics at the Departments of Pharmacy at the University of Groningen, Pharmacology at the Airlangga University in Surabaya and Pharmaceutical Care Innovation at Universitas Padjadjaran in Bandung, both located in Indonesia. He specifically leads a team of sixty staff, PhD and post-doc researchers in health- and pharmacoeconomics, contributing to many international research networks and scientific communications. Research areas comprise cost-effectiveness methods, for example, in vaccinology, transfusion science, prevention of (complications) of chronic diseases, orphan drugs and personalized medicine. He serves and served on various committees advising the Dutch government on reimbursement of drugs and vaccines (CVZ/ZiNL and Health Council). Also, he is advisor to various health-economics consultancy companies and pharmaceutical companies worldwide, Ministries of Health in neighbouring countries, member of editorial boards of scientific journals, on advisory boards for pharmaceutical companies, expert consultant for WHO and member of WHO’s SAGE-committees. He is a member of UK’s Joint Committee of Vaccination & Immunization and advisor to the All Wales Medicines Strategy Group (Grwp Strategaeth Meddyginiaethau Gymru Gyfam). He is specialized in the role of pharmacoeconomics/health economics in the reimbursement process. Maarten holds a MA in econometrics and a PhD in health economics. top

Csilla Pozsgay | Hungary | 2017

Csilla Pozsgay is currently the General Director of the National Intitute of Pharmacy and Nutrition in Hungary. She graduated from medicine at the Semmelweis University (Hungary). She has two medical specialisations: reumatology and physiotherapy. She has experience in managing clinical trials and acting as regulatory expert and supporting clinical trial submissions. From 2011 till 2013 she was Director of Medical and Scientific Affairs at National Institute of Pharmacy (Hungary). Then she was a Medical Director at MSD Magyarország Kft. (2013-2015). top

Tomasz Jan Prycel | Poland | 2017 2018 2019 2020 2021 2022 2023 2024

Managing Director of CEESTAHC. Graduate of the Faculty of Medicine of the Medical University in Łódź and Postgraduate  Health Care Management Studies in the Nofer Institute of Occupational Medicine. Expert in cooperation and creation of health projects with local government units, with many years of experience in creating an educational platform for developing high-quality health programmes in important areas of public health. President of the European Foundation for Solving Health Problems (Europejska Fundacja Rozwiązywania Problemów Zdrowotnych). Co-creator of the “Zdrowie/Człowiek/Profilaktyka” educational programme, aimed at local governments and employers. Initiator of www.dobreprogramyzdrowotne.pl, a website containing a Health Programme Creator and educational materials for creators of health policy programmes. top

Maria Psenkova | Slovakia | 2016

She founded and currently leads the company Pharm-In, Ltd, offering its services in the field of Market Access (registration, pricing and reimbursement, pharmacoeconomics) that works since 2008. Maria Psenkova has an extensive experience in management positions in the pharmaceutical industry. Worked in marketing, sales and market access and with her teams successfully introduced to the pharmaceutical market several innovative medicines in various therapeutic areas. She has experience in the execution of drug policy regulation, she worked as advisor to the Ministry of Health and as consultant for Health Insurance Company. Since 2011 she is lecturer at Slovak Medical University and currently holds the position of Past President at ISPOR chapter Slovakia. top

Michał Rataj | Poland | 2017 2019

Graduated from the Faculty of Computer Science at the University of Silesia, profession IT specialist. As a patient, actively involved in patient organizations for over 20 years. Board Member of European Patients Forum (EPF). I am also pleased to represent EPF in Patients’ and Consumers’ Working Party (PCWP) within the European Medicines Agency (EMA). Through the EMA, I am involved in various projects as digital and media working group, electronic product information, vaccination and more. I am also a board member of the Polish Neuromuscular Diseases Association (PTCHNM) and European Alliance of Muscular Dystrophy Associations (EAMDA Slovenia). Co-organiser of many international and national conferences for patients with neuro - muscular diseases. Co-author of publication:“Be an ambassador for change that you would like to see”: a call to action to all stakeholders for co-creation in healthcare and medical research to improve quality of life of people with a neuromuscular disease (Orphanet Journal of Rare Diseases). In private life - enthusiast of modern technologies and modern devices facilitating mobility. top

Elizabeth A. Rider | USA | 2022

Elizabeth A. Rider, MSW, MD is a pediatrician and medical educator; leader of the Transforming Healthcare Relationships: Values, Learning Environments, and Organizational Culture project; and founder and Director, Boston Children’s Hospital / Harvard Medical School Faculty Fellowships in Humanism/ Professionalism, and Interprofessional Leadership. On the faculty of Harvard Medical School and the Harvard Macy Institute, she directs the international course Difficult Conversations in Healthcare. She served as Director of Academic Programs for the former Institute for Professionalism and Ethical Practice (2007-2020). Dr. Rider is a senior fellow and former Chair of the Medicine Academy of the National Academies of Practice. She is a founder of the International Consortium for Communication in Healthcare (IC4CH) and leads the International Charter for Human Values in Healthcare initiative, an interprofessional collaborative effort to restore attention to core values and skilled communication in healthcare. She also serves as an Associate Editor for Patient Education and Counseling. Dr. Rider has been recognized internationally for her work and has been an invited speaker / consultant in 10 countries. Her current research includes relational learning, values, communication skills, professionalism, medical /interprofessional education, as well as national collaborative studies to identify promoters /barriers to humanistic practice and education, and humanistic leadership and organizational culture change to mitigate burnout and enhance wellbeing. top

Paulina Rolska-Wójcik | Poland | 2016 2017 2019

Business development & project manager w firmie HTA Consulting. Poprzednio specjalista ds. ekonomiki zdrowia w dziale Market Access w GlaxoSmithKline. Od 2014 do 2016 roku współpracowała z firmą MedInvest Scanner, zajmującą się oceną ryzyka inwestycyjnego w innowacyjne nielekowe technologie medyczne oraz due diligence. W latach 2013-2014 audytor w firmie HTA Audit zajmującej się oceną jakości analiz wchodzących w skład raportu HTA. Z wykształcenia doktor nauk o zdrowiu. Autorka wielu publikacji. top

Tomasz Rowiński | Poland | 2024

Doctor of Psychology, assistant professor at the SGH Warsaw School of Economics – ThinkTank SGH for health care, member of the Council for Mental Health at the Minister of Health, member of the Social Welfare Reform Team at the Minister of Family, Labour and Social Policy, member of the Child Death Review Team at the Minister of Justice. He is the author or co-author of more than forty publications and presented sessions or lectures at more than 100 scientific and professional conferences in the field of mental health. He created the first community mental health centre for children and youth. He based the centre on a scientifically validated model of mental health, which was the basis for organising public services for families, children and youth. He was awarded the “Golden Synapse” distinction by the psychiatric community for his idea and its implementation. What is more, he was involved in the implementation of the model of deinstitutionalisation of public mental health services for children and youth in many parts of Poland. He is the initiator of databases for public policy, which are essential for decision-making in public services at government and local government levels. Tomasz Rowiński is committed to establishing the legal basis and mechanisms for multisectoral cooperation in the area of mental health from the public value perspective. top

Andrzej Ryś | Poland | 2022

Polish physician; he was Undersecretary of State in the Ministry of Health in the years 1999–2001 and has been a Director in the European Commission since 2006; on 1 October 2022 he was appointed Principal Scientific Advisor in DG Sante. He graduated from the Faculty of Medicine at the Medical University of Nicolaus Copernicus in Cracow. Between 1990 and 1997, Andrzej Ryś created and was the Principal of the Institute of Public Health of the Jagiellonian University Medical College. In the years 1997 and 1999 he was Head of the Cracow City’s Health Department. He was Deputy Minister between 24 June 1999 and 22 October 2001 at a time when Jerzy Buzek was Prime Minister. His focus was on international cooperation and Poland’s integration with the EU, reforming emergency medical services and training in medical professions. Andrzej Ryś was a member of the Negotiation Team led by Jan Kułakowski, where he was responsible i.a. for harmonisation of the Polish law and EU regulations. In late 2002 he founded the Centre for Innovation, Technology Transfer and University Development” (CITTRU) at the Jagiellonian University, where he was Director until 2006. In the years 2004-2005, he was also the director for strategy at Diagnostyka and in 2005 and 2006 he was the managing director of the National Association of Private Health Care Employers. On 1 June 2006 he assumed the position of director at the Directorate-General for Health and Food Safety (DG SANCO), responsible for public health affairs, and later for health systems, medical products and innovation. He was also a consultant to the World Health Organization and the World Bank. top

Przemysław Ryś | Poland | 2018 2019 2020

The Clinical Analyses Department's Director in HTA Consulting. A doctor by education, he graduated from Collegium Medicum of the Jagiellonian University and worked in the J. Dietl Specialist Hospital in Krakow and the Krakow University Hospital. Przemysław heads the Clinical Analyses Department and supervises projects carried out in Poland and the rest of Europe. He is the author of clinical and methodical publications as well as a reviewer of scientific journals. He has a great eye for detail and the ability to ask inquisitive clinical and methodical questions. top

Joanna Rzempała | Poland | 2021

PhD in economics, Senior Lecturer in the Department of Organisation and Management at the Faculty of Economics, Finance and Management of the University of Szczecin. Lecturer in the field of project management. She is the director and a lecturer of "Project Manager" postgraduate studies at the University of Szczecin. Vice President of IPMA Poland responsible for student certification and cooperation with universities. Manager of teaching and business projects, independent consultant specialising in project financial management. IPMA-Student Programme Manager, Coordinator of the National Project Master Competition for the best diploma thesis in project management. She holds the title of Certified Senior Project Manager IPMA-B, the Green Project Management Global- b Certificate and the certificate of the Ministry of Finance for providing accounting services as well as the PRINCE2 Foundation project management certificate. She was awarded the title of Project Management 2015 Atlas for spreading the idea and knowledge of project management in Poland. Author of scientific publications, including in the field of management. She has been a member of the Finance Committee of IPMA International since March 2018.  top

Katarzyna Sabiłło | Poland | 2017

Prezes Zarządu Fundacji Lege Pharmaciae. Absolwentka Wydziału Farmacji Uniwersytetu Medycznego w Warszawie (1995) oraz podyplomowych studiów w zakresie zarządzania prowadzonych na Uniwersytecie Łódzkim we współpracy z Uniwersytetem w Lionie we Francji (1996), z ukończonym kursem "European Regulatory Affairs Course" organizowanym pod auspicjami EMEA (2002). Wielokrotny reprezentant Związku Pracodawców Innowacyjnych Firm Farmaceutycznych INFARMA, w pracach parlamentarnych nad kolejnymi nowelizacjami Prawa Farmaceutycznego. Członek Zespołu ds. Nowelizacji Prawa Farmaceutycznego powołanego przez Ministra Zdrowia (2006). Wykładowca w Collegium Medicum Uniwersytetu Jagiellońskiego oraz na Uniwersytecie Łódzkim. W latach 1997-2008 dyrektor ds. Rejestracji i Regulacji Prawnych w Berlin-Chemie / Menarini Polska Sp. z o.o. Od 2009 r. prowadzi własną firmę doradczą specjalizującą się w szeroko rozumianych kwestiach regulatorowych. Współfundator Fundacji Lege Pharmaciae zajmującej się krzewieniem zasad dobrej legislacji w sektorze ochrony zdrowia. top

Stefan Sauerland | Germany | 2019

Stefan Sauerland joined IQWiG (Institute for Quality and Efficiency in Healthcare) in January 2010. As Head of the Department for Non-Pharmacological Treatments, he is responsible for the scientific evaluation of non-pharmacological therapies (including medical devices), diagnostic tests and control procedures. IQWiG is responsible for the preparation of evidence-based reports that support reimbursement decisions at national level within the German healthcare system. Prof. Sauerland has more than 12 years of experience in surgical research, first at the University of Cologne and then at the University of Witten/Herdecke. His main areas of interest have been clinical trials, clinical guidelines and meta-analyses. He has published more than 250 articles, more than 150 of which are in the Medline database. In 2005, he received the DKV Cochrane Award for his review of laparoscopic appendectomy for Cochrane. He obtained his MD from the University of Cologne and his M.P.H. from the University of Dusseldorf. In 2019, he became an assistant professor at the University of Cologne. top

Natalie Schellack | South Africa | 2022

Natalie Schellack is a registered pharmacist, Professor and currently the Head of the Department of Pharmacology, University of Pretoria. She holds three degrees, two bachelor degrees (nursing and pharmacy) and a PhD in Pharmacy. Outside the University, she serves on the South African Pharmacy Council (as an elected member of council) and the Ministerial Advisory Committee for Antimicrobial Resistance (MAC-AMR). Her research interests are centred on the broad area of clinical pharmacy as related to paediatrics, ototoxicity and infectious diseases (e.g., TB and HIV). More specifically interested in quantifying antimicrobial utilisation data, pharmacokinetic and dynamic levels of antibiotics in blood levels. More recently her research area has been more focused on finding innovative ways of measuring antimicrobial utilisation using health technology. She is a cofounder of the South African Society of Clinical Pharmacy (SASOCP). In 2018 she has also been nominated as the woman of the year – health care category for “woman of stature” in South Africa. She is also a rated researcher (C2) as awarded by the National Research Foundation (NRF), furthermore she is the fourth elected member of the South African Antimicrobial Stewardship Programme (SAASP). top

Michael Schlander | Germany | 2023

Michael Schlander is Professor of Health Economics (at AWI – Alfred Weber Institute for Economics and at the Mannheim Medical Faculty) of the University of Heidelberg, currently on leave of absence to act as foundation Head of the Division of Health Economics for the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), Heidelberg, Germany (since 2017). He has been founding chairman of the not-for-profit “Institute for Innovation & Valuation in Health Care” (InnoValHC e.V.) in Wiesbaden, Germany (since 2005), and has acted a scientific advisor of its consulting and management branch, Inno-Val-HC-Forschungsgesellschaft mbH (InnoValHC Research Inc., also since 2005).  He is a member of numerous scientific associations, including the Drug Information Association (DIA), the International Health Economics Association (iHEA), and the International Society for Pharmacoeconomics and Outcomes Research (ISPOR); in 2008, he was a co-founder of the German Society for Health Economics (Deutsche Gesellschaft für Gesundheitsökonomie, DGGÖ). He further acted as the scientific program chair for the 15th Annual European Congress of ISPOR in 2012, with more than 3,500 attendants. After six years in experimental brain research and clinical neurology (at the Universities of Frankfurt a.M. and Mainz), he joined the international biopharmaceutical industry in 1987, where he spent 15 years in executive roles in clinical development (1987-1993), marketing (1993-1999), and general management (1999-2002) in Belgium, Germany, Switzerland, and the United States. His scientific publications include two monographs, on ‘The Contribution of Health Economics to Market-Oriented Pharmaceutical Research and Development’ (Witten/Herdecke University Press; Witten, Germany: 1998) and on ‘Health Technology Assessments by the National Institute for Health and Clinical Excellence (NICE)’ in England and Wales (Springer; New York, NY: 2007).  top

Ad R. Schuurman MBA | Netherlands | 2017

Head of Business Contact Centre and International Affairs of the Dutch National Health Care Institute (ZIN). President of the Medicines Evaluation Committee (MEDEV) Ad Schuurman completed his study in Utrecht as a clinical psychologist in 1980. He subsequently worked for five years as head of a patients’ association. In the following years, as staff officer of a regional Institute for Mental Health, he organized the cooperation the Regional Institutes for Mental Health and the other healthcare organisations. After spending several years as manager of the national project relating to pharmacy therapeutic decision making, he became head of a geriatric department. In the meantime he completed studies on management consultancy and on business administration (MBA). As deputy director of the Dutch College of General Practitioners (NHG), he set up the Electronic Prescription System. In recent years, as manager of the Pharmacy department, he was responsible for the pharmacy-related activities of the ZIN. Since 2006 he was head of the Reimbursement Department, covering all healthcare reimbursement issues in the Netherlands. In 2006 he became President of the Medicine Evaluation Committee (MEDEV) in Brussels, in which reimbursement authorities of 20 EU countries cooperate. Since 2010 is Ad Head of Business Contact Centre and International Affairs of the National Health Care Institute (ZIN). top

Holger Schünemann | Canada | 2020

Prof. Schünemann is Chair of the Department of Health Research Methods, Evidence, and Impact (formerly “Department of Clinical Epidemiology and Biostatistics”). He is director of Cochrane Canada, co-director of the McMaster University WHO collaborating center for evidence informed policy-making (until 2018) and the McMaster GRADE center, co-chair of the Guidelines International Network and International Network of Health Technology Agencies (GINATHA) working group. He has served as methods lead on over 20 European Commission and WHO expert guideline committees and served as adviser to member countries. From 2005 to 2009 he was at the Italian National Cancer Center in Rome, Italy, serving as interim chair of the department of Epidemiology from 2007 to 2009, before moving to McMaster University as full-time Professor and to become Chair of Clinical Epidemiology and Biostatistics. He completed his second and final term a chair in June 2019 and focuses now on research and implementation projects related to guidelines and systematic reviews. He has been advisor to ministries of health, other governmental organisations and numerous professional societies for their knowledge synthesis and guideline programs and is co-chair of the GRADE working group (www.gradeworkinggroup.org) where he was instrumental in the creation of 16 GRADE centers and networks globally. His scientific work focuses on evidence synthesis, quality of life research and the presentation and development of health care recommendations spanning clinical medicine to public health. He has authored or co-authored over 600 peer-reviewed publications, has been named by Thomson Reuters as one of the most influential 3,000 scientific minds of current times yearly since 2015, and is on the list of the 1500 most cited scientists of all times. As editor in Chief, he leads the journal Health and Quality of Life Outcomes. Maintaining an active internal medicine practice fulfills his passion for patient care and ensures his research is people-oriented. top

Michał Seweryn | Poland | 2023

President of EconMed Europe, graduate of CMUJ, specialist in public health and epidemiology, Doctor of Economics in the field of health economics. He specialises in health economics, HTA and drug management. An expert at the European Commission (evaluating grants in the HORIZON programme), long-time lecturer of HTA and health economics – assistant professor at Collegium Medicum of the Jagiellonian University (2009-2016). In the past, he served as the Lesser Poland Provincial Sanitary Inspector and the Head of the Department of Drug Administration of the Lesser Poland Provincial Branch of the National Health Fund. Michał Seweryn is the author of scientific publications and specialised studies in the field of health economics and epidemiology. top

Nabil Seyidov | Azerbaijan | 2022

Dr Nabil Seyidov has been working as a physician with specialisation in internal medicine and cardiovascular diseases for over 15 years. Since 2014 he has been actively involved in promotion and developments of public health system in Azerbaijan with specific interests in primary health care, health economics, palliative and hospice services, neonatal care, e-health and medical training and education. As a head of health policy and planning department of Public Health and Reforms Center of Ministry of Health, Dr. Seyidov has been an initiator and coordinator of many projects as well as co-investigator of several research studies including COSI, HBSC and COVID19 Vaccine effectiveness among healthcare workers. He was also co-investigator in the cross-sectional national study on trust in healthcare system. He is an author and co-author of over 50 training manuals, books and guidelines and 15 scientific articles in peer-reviewed scientific journals. He is also an editor-in-chief of Eurasian Journal of Clinical Sciences. top

Markus Siebert | Belgium | 2018

Senior Director Reimbursement & Healthcare Economics, International (Abbott, Belgium). Markus Siebert was named Senior Director Reimbursement & Healthcare Economics of the International Division at St. Jude Medical (now Abbott) in January 2012. He is responsible for the development and execution of reimbursement strategies and for leading the development of health economic evidence in support of Market Access of Abbott innovations in Europe, Asia and Australia. Work with multiple stakeholders, including payers and HTA agencies is of considerable relevance to this work. Markus is currently Chair of the Evidence & Payers Working Group at MedTech Europe (previously Eucomed), the European medical technology association; past Chair of Eucomed Working Groups on Economics and on Telemonitoring; a member of the Cardiovascular Roundtable of the European Society of Cardiology; and company representative on the HTAi Policy Forum. Markus was co-initiator and Board Member of EHTI, the European Health Technology Institute for Socio-Economic Research. Markus joined St. Jude Medical in January 2004 after almost seven years at Eucomed (now MedTech Europe), where he headed the Economic Affairs Department. He holds a Master Degree in Economics from the University of Bochum (Germany) and a Master in Health Economics from VLEKHO, Belgium. top

Steven Simoens | Belgium | 2017

Steven Simoens currently is a full Professor of health economics at KU Leuven. Since 2011, he is a member of the board of the Department of Pharmaceutical and Pharmacological Sciences at KU Leuven. Since April 2013, he is the head of the unit Clinical Pharmacology and Pharmacotherapy in the Department of Pharmaceutical and Pharmacological Sciences at KU Leuven. Steven Simoens is a Commercial Engineer (KU Leuven, 1997), who later specialised in health economics and obtained a MSc in Health Economics (University of York, 1998) and a PhD in Economics (University of Aberdeen, 2001). top

Jacek Siwiec | Poland | 2023 2024

Sociologist – HTA expert – with more than 20 years of professional experience in public and private institutions related to health technology assessment (HTA/EBM), total quality management (TQM), clinical indicators, quality of life assessment, health insurance, and clinical research. He has held management positions in the CEESTAHC Association, WHC and Medicea Foundations, clinical research centres and numerous companies involved in broadly defined quality, ancillary insurance, and HTA. He currently holds the position of Director at the AOTMiT’s Branch Office in Cracow. He was the initiator and organiser of the International EBHC Symposium (2004-11) of the CEESTAHC Association, and of the conference series entitled “Innovations in Medicine” of the WHC Foundation. Jacek Siwiec is a manager, organiser, coach in trainings and several hundred training programmes in the field of EBM/EBHC/HTA/GCP, and an academic lecturer – at i.a. postgraduate studies in HTA at Institute of Public Health at Jagiellonian University Medical College (PRO-QUO HEALTH, HB-HTA). He has held advisory roles as, i.a., a member of the Ministry of Health’s Team for the Translation of Maps of Healthcare Needs, expert of the AOTMiT’s Tariffs Council, HTA coordinator of the Pointer project. Additionally, he is a member of teams and co-author of the Minister of Health’s “IOWISZ” tool. Jacek Siwiec is the co-author of HTA studies and expert consultations for Ministries of Health of the following Serbia (on behalf of the World Bank) and Ukraine. He has cooperated with various international institutions such as WHO (HEN), EUnetHTA, HTAi, World Bank and DG SANCO – member of the Expert Group on Health Systems Performance Assessment (HSPA), as well as Polish and foreign universities. Currently, he participates in several task forces and consulting teams, such as Voivodship Health Needs Mapping Teams, or in the work of the President of the Republic of Poland’s Working Group on 75 + Centres, as well as in the work of the Steering Committee for the Coordination of EFSI Interventions in the Health Sector. He has been an expert member, Polish representative for HTA methodology to the EU team – Coordination Group on Health Technology Assessment (CG-HTA), dealing with the commonality of HTA activities in the EU, since 2023. top

Iwona Skrzekowska-Baran | Poland | 2018

Iwona graduate of the Faculty of Medicine of the Jagiellonian University Medical College in Cracow. She wrote her doctoral thesis in medicine and completed MBA studies with a specialisation in the field of Health Technology Management. For over 20 years her focus has been on healthcare systems, pharmacoeconomics, health technology assessment and drug pricing. She is a member of HTAi, ISPOR, PTFE. top

Małgorzata Skweres-Kuchta | Poland | 2019 2021

PhD in economics, professionally involved with the University of Szczecin; her field of work involves management of healthcare systems and support for children with rare diseases; member of the Council of Experts on Rare Diseases at Medyczna Racja Stanu (Medical National Interest, Polish think-tank), CEO of Platynowa Drużyna (Platinum Team Foundation) – patient organisation for patients with type 2 neuronal ceroid lipofuscinosis (CLN2); member of the NCL Gruppe Deutschland e.V. patient organisation. top

Agnieszka Słowik | Poland | 2018

Head of the Department of Neurology and the Neurogenetics Facility at the Collegium Politicum of the Jagiellonian University. She is also the head of the Centre of Interventional Acute Stroke Therapy (CITO) at the University Hospital in Cracow. She is a member of the Committee of Medical Sciences of the Cracow branch of the Polish Academy of Sciences (PAN), the Committee of Neurological Sciences of PAN, and the Scientific Council of the Institute of Pharmacology of PAN in Cracow. She belongs to the European Stroke Organisation, the American Neurological Association and the American Neurological Academy. Since 2008 she has belonged to the International Stroke Genetics Consortium and is now a member of this organisation's Steering Committee. As part of the consortium, she conducts research centred on the search for genetic risk factors for various etiologies of stroke. Many of these studies are published in leading scientific journals, e.g. Nature Genetics, Lancet Neurology or American Journal of Human Genetics. Her scientific interests include the issues of pathophysiology, clinic and stroke therapy and other age-related nervous system diseases. She is the author of over 150 papers in this field and has been quoted over 3400 times. She has obtained 12 national scientific grants and 15 international ones. She has won 10 scientific awards, including two awards from the Polish Academy of Sciences, two from the Minister of Health and three from the Minister of Science. In 2018, Prof. Agnieszka Słowik, together with Prof. Tadeusz Popiela, has received the Prime Minister's award for organising and coordinating a system of causative treatment of ischemic stroke via mechanical thrombectomy (CITO), addressed to the residents of Małopolska. As part of this system, 200 patients were treated using mechanical thrombectomy. top

Sophie Söderholm Werkö | Sweden | 2021

Manager International Relations & Patient Engagement, The Swedish Agency for Health Technology Assessment and Assessment of Social Services. Sophie has an MSc in Business Administration and a PhD from the University of Stockholm. She has a longstanding engagement with HTA and started in HTA as Project Director at The Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU). In 2012 she was appointed Manager of International Relations at SBU, responsible for coordinating SBU’s international work and she is also leading the work on Patient Involvement at SBU. As Chair of the International Network of Agencies for Health Technology Assessment (INAHTA) until 2020, she had an important role of leading the global network of publicly funded HTA agencies. She has participated in the work of the European network for Health Technology Assessment (EUnetHTA) since 2009 and represents Sweden in the EU HTA Network (HTAN). Recently she acted as regional advisor to the WHO Egypt office and the WHO in the EMRO Region. She publishes frequently in scientific journals and acts as reviewer and associated editor in several journals. top

Sophie Staniszewska | UK | 2021

Prof. Sophie Staniszewska prowadzi program badawczy Patient and Public Involvement and Engagement (PPIE) oraz Experiences of Care w Warwick Medical School w Anglii. Skupia się na rozwijaniu bazy dowodowej PPIE w obszarach takich jak modelowanie matematyczne i ekonomiczne, genomika i pozyskiwanie danych oraz infekcje układu pokarmowego. Ostatnio wraz z dr Sophie Werko współredagowała specjalne wydanie czasopisma medycznego International Journal of Technology Assessment in Health Care, skupiające się na zaangażowaniu pacjentów i społeczeństwa w HTA (ocenę technologii medycznych). Sophie była współprzewodniczącą podgrupy Methods and Impact (wraz z dr Werko) w Citizen and Patient Involvement HTAi Interest Group. Sophie jest współredaktorem naczelnym czasopisma Springer Nature Journal, Research Involvement and Engagement. Sophie jest członkiem-założycielem Międzynarodowej Sieci PPI, której celem jest stworzenie globalnego zrozumienia i synergii w zakresie zaangażowania pacjentów i społeczeństwa w badania nad zdrowiem i opieką społeczną. top

Mitchell Sugarman | USA | 2016 2017

President and CEO at Anchor Bay Consulting. He was Vice President of Global Health Economics, Policy and Payment for Medtronic’s CardioVascular Division. In this role, he was responsible for ensuring that reimbursement is a consideration in every functional area from product conception, through research and development, clinical and regulatory affairs, product launch and marketing. Prior to joining Medtronic, Mr. Sugarman worked at Kaiser Permanente for 19 years initially as the Director of a clinical genetics department, and later as the Director of Medical Technology Assessment. This position involved tracking new drugs, devices and procedures as they moved from experimental to non-experimental, and determining whether they should be part of the medical armamentarium. Critical issues evaluated included safety, efficacy and cost-effectiveness. top

Wojciech Szefke | Poland | 2017

Wojciech Szefke has a master's degree in law, history and administration of the Nicolaus Copernicus University in Toruń. In the years 2003-2007 he acted as legislator of the Ministry of Health, was responsible for preparation of bills, drafting legal analyses and cooperation with legal departments of EU institutions. Deputy Public Finance Auditor. He has been a university lecturer for approx. 11 years. Wojciech Szefke graduated from Legisative Studies. Since 2007 his clients include key companies in the medical devices market. He has cooperated with the National Chamber of Commerce for Medical Devices POLMED for 7 years. President of the Board of the Medical Industry Employer Organisation Technomed. Author of numerous publications on the medical devices market and public procurement law. top

Aleksandra Sztuder | Poland | 2024

Representative of the Director of the Lower-Silesian Centre of Oncology, Pulmonary and Haematology (DCOPiH) in Wroclaw in matters related to the comprehensive cancer care network. top

Andrzej Śliwczyński | Poland | 2017 2018

Doctor of Health Sciences, a graduate of the University of Łódź, obtained his scientific title at the Medical University of Łódź. Deputy Director of the Department of Analyses and Strategy in the Central Office of the National Health Fund, lecturer at the Humanities and Economics Academy in Łódź. Between 1987 and 2005 he worked and held managerial positions in the State Pharmaceutical Supply Company "Cefarm". Since 2005 he has been working at the Central Office of the National Health Fund. In 2012 he obtained postgraduate diploma of Database Studies. Currently, he deals with analysis of large data sets concerning actual clinical practice. Author and co-author of dozens of articles published in national and international journals in the field of medicine and economics, discussing medical data analyses, financing in the health care system, epidemiology, pharmacoeconomics. Member of the Transparency Council of the Agency for Health Technology Assessment. top

Bartosz Świdrak | Poland | 2017

Attorney-at-law, senior associate at FAIRFIELD Law Firm (previously: DFL Legal), legal expert at the Polish Chamber of Commerce of Medical Devices POLMED. A specialist in Life Sciences, he has been involved in the medical devices industry for many years. His experience includes comprehensive consulting for manufacturing companies, i.a. within the scope of promotion and advertising activities, matters related to supervising the trade of medical devices or issues concerning compliance and legal risk management for companies. He has conducted many internal audits in medical companies. Furthermore, Bartosz Świdrak has experience in the field of training, i.a. workshops dedicated to sales and marketing departments, as well as management boards, in the field of compliance, advertisement law and control procedures. Mr. Świdrak represents clients in the broad range of proceedings: administrative, civil as well as proceedings before the National Appeal Chamber with regard to public procurement. top

Tomasz Tatara | Poland | 2020 2024

Doctor of Health Sciences, public health specialist, graduate of the Medical University of Warsaw. Tomasz Tatara has several years of professional experience as an academic worker and as a pharmacoeconomics and HTA analyst. He acts as Head of the Health Policy Programme Division of the Technology Assessment Department at the Agency for Health Technology Assessment and Tariff System, . Former member of the Prevention Measures Coordination Team of the Minister of Health, the Team for the development of a recovery plan for cancer prevention strategies in relation to the SARS-COV-2 pandemic and the Team for systemic changes in public health. Currently, he is a member of the Provincial Council for health needs for the Warmian-Masurian Voivodeship. He is the author of numerous scientific publications, scripts, monograph chapters in the field of public health, healthcare, and pharmacoeconomics. Additionally, Tomasz Tatara has carried out numerous pharmacoeconomic analyses on the assessment of drug technologies available under drug programmes and health policy programmes. He gives lectures on public health and pharmacoeconomics at the Medical University of Warsaw. top

Victoria Thomas | UK | 2020

Victoria Thomas BA (Hons), MSc (Dist), Head of Public Involvement National Institute for Health and Care Excellence (NICE). Victoria Thomas has run the Public Involvement Programme at NICE since 2009, and has been with the Programme since 2001. Following a degree in Art History, Victoria has worked exclusively in the public and voluntary sector, specialising in healthcare quality improvement activities and in patient and public involvement. Victoria’s MSc, in Science and Society, concentrated on issues of science communication, science and the public, and lay people’s engagement with evidence-based healthcare initiatives. Victoria has an interest in shared decision-making, in particular the role of national clinical guidelines as the basis of informed decision-making by both patient and clinician. top

Krzysztof Tomasiewicz | Poland | 2023

Head of the Department and Clinic of Infectious Diseases and Hepatology of Medical University of Lublin. A long-time member of the board of the Polish Association for Study of Liver (PASL), vice-president of the Polish Society of Epidemiology and Infectious Diseases Physicians (PTEiLChZ). Founding member of CEHC. Head of numerous projects of national and international research. Principal researcher in over 20 clinical trials in the field of infectious diseases and hepatology. Chairman of the Polish NAFLD/NASH Expert Group, Chairman of the Polish HCV Expert Group, Member of the Polish HBV Expert Group, Member of the Expert Group for Combating Healthcare-Associated Infections. Former member of the National COVID-19 Medical Council. Reviewer of the European Association for the Study of Liver Disease (EASL) International Liver Congress for the years 2019-2021. Expert on the HCV elimination at the invitation of the World Health Organisation (WHO. Co-author of the national recommendations for the management and treatment of HCV, HBV, NAFLD/NASH and ricketsioses. Frequent reviewer of therapeutic programs for the Agency for Health Technology Assessment and Tariff System, as well as research projects for the National Science Centre (NCN). Member of the Scientific Committee of joint project "International Transfer of Health Data" The European Federation of Academies of Sciences and Humanities (ALLEA), the European Academies' Science Advisory Council (EASAC) and Federation of European Academies of Medicine (FEAM). In recent years, very close cooperation with the Department of Gastroenterology and Hepatology, Essen University Hospital in Essen (Germany) and the Department of Gastroenterology, Hepatology and Endocrinology, Medical School Hannover (Germany). Krzysztof Tomasiewicz is the author of numerous original and review works of total IF of over 350 and a number of citations of over 6000, h-index 23. Editor-in-Chief of “Clinical and Experimental Hepatology”, Guest Editor in the field of Gastroenterology of the Frontiers publishing house. top

Roman Topór-Mądry | Poland | 2017 2018 2019 2020 2021

Roman Topór-Mądry, MD – President of the Agency for Health Technology Assessment and Tariff System. Doctor, specialist in public health, epidemiologist. Regional consultant in public health for the Małopolskie voivodeship. Deputy Director of the Institute of Public Health of the Faculty of Health Sciences at the Jagiellonian University Medical College. Participant and coordinator of many research projects, he worked in advisory teams to, i.a. the Ministry of Health, scientific societies, local governments, the European Commission, the World Bank. top

Joanna Turkiewicz | Poland | 2024

Author of scientific publications, academic lecturer, and trainer with many years of experience. She is a practitioner in the field of using modern technology in education and academic writing. Joanna Turkiewicz has conducted trainings and workshops for physicians on image development on the Internet in cooperation with the Supreme Medical Chamber and on publishing scientific articles at the Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, where she is currently working. Her scientific interests revolve around patient experience and broadly understood healthcare. top

Ewa Urban | Poland | 2021 2022

Ewa Urban, MD, has worked in the National Institute of Public Health PZH – National Research Institute, in the Department of Health Promotion and Chronic Disease Prevention as Senior Technology Research Specialist, and she has been acting Head of that Department since 2018. Moreover, she is a lecturer at the Postgraduate Medical Education Centre and at the College of Rehabilitation in Warsaw. Ewa Urban is the co-author of scholarly articles in the field of public health and health promotion. She took part in numerous projects, incl. ProfiBaza — digital sharing of public information about the people’s health-related situation and implementation of health programmes addressing disease prevention and health promotion in Poland; Priority on NCD: Increased access to interventions to prevent and manage noncommunicable diseases and their risk factors; Development of an innovative set of indices in the public health area, tailored for the Polish healthcare system; Local partnerships benefiting residents; Assessment of necessary public health actions taken in Poland (EPHOs). top

Mieczysław Walczak | Poland | 2016

Mieczyslaw is Head of: the Department of Paediatrics, Paediatric Endocrinology, Diabetology, Metabolic Diseases and Cardiology at the Pomeranian Medical University in Szczecin, the Coordination Team for Growth Hormone Application and the Coordination Team for Ultra-rare Diseases. He is a member of the Team for Rare Diseases advising the Minister of Health. He co-founded the Polish Registry of Congenital Malformations. He is the National Consultant in the field of paediatric endocrinology and diabetology. He is the Head of the Polish Society of Paediatric Endocrinology and Diabetology. He is a member of: the General Board at the Polish Paediatric Society, the Social Council at the Western Pomeranian Child Hospice and the Senate of the Pomeranian Medical University in Szczecin. Between 2006 and 2013, he was Head of the Council of Clinicians – the Chief Medical Doctor of the Independent Public Clinical Hospital no. 1 in Szczecin. Mieczyslaw Walczak is a member of the Scientific Council at the Children’s Memorial Health Institute in Warsaw and the Scientific Council at the Institute of Mother and Child in Warsaw. He authored or co-authored over 450 publications and statements from conventions and scientific conferences. He was awarded the Silver Cross of Merit and the Gold Medal for Long Service. He was also distinguished by i.a. the Silver Honorary Badge of the Szczecin’s Griffin and the Józef Polikarp Brudziński Honorary Medal. He graduated from the Faculty of Medicine at the Medical Academy of Poznań. top

Ewa Warmińska-Friberg | Poland | 2016 2017 2024

Attorney-at-law and manager with many years of experience in public administration and advisory for the benefit of healthcare actors. She specialises in financing of healthcare services, including reimbursement of medicines and medical devices. Currently, she is a member of the management board of Technomed. Ewa co-authored the commentary on the Act on the Reimbursement of Medicines, Foodstuffs Intended for Particular Nutritional Uses and Medical Devices, as well as numerous practical commentaries on health care. She gained experience while working at the National Health Fund, the Agency for Health Technology Assessment and Tariff System (AOTMiT) and the Ministry of Health, where she held the position of Deputy Director at the Department of Drug Policy and Pharmacy and was responsible in particular for creating the drug policy in Poland, legislation, and reimbursement. Additionally, she was a member of the Tariff Council and represented Poland in various committees and working groups at the EU level. top

Björn Wettermark | Sweden | 2021

Björn Wettermark, M.Sc.Pharm, PhD is professor of pharmacoepidemiology at Uppsala university, Sweden and visiting professor at Vilnius university, Lithuania. His research focus mainly on drug utilization as a tool in health policy including prescribing quality indicators, international comparisons of drug utilization, evaluation of prescribing doctors´ adherence to guidelines and patient adherence to treatment as well as intervention studies to promote rational use of drugs. He has previously had various managerial positions in the health region of Stockholm as well as other commitments including membership in national and regional strategic groups on medicine management, scientific advisor to the Swedish Medical Products Agency as well as past chair of the European Drug Utilization Research group, the European chapter of the International Society for Pharmacoepidemiology. top

Wojtek Wiercioch | Canada | 2017

Research methodologist at the McMaster GRADE Centre in the Department of Health Research Methods, Evidence, and Impact (McMaster University, Hamilton, Canada). He specializes in evidence synthesis, guideline development methodology, and the guideline development process. As a member of the GRADE (Grading of Recommendations Assessment, Development and Evaluation) Working Group, his focus is on application and training on the GRADE approach for systematic reviews and guidelines. His main research activities include systematic reviews and the development of clinical practice guidelines in collaboration with various medical specialty societies, healthcare organizations, and ministries of health. He completed his graduate training in the Health Research Methodology program at McMaster University. top

Magdalena Władysiuk | Poland | 2016 2017 2018 2019 2020 2021 2022 2023 2024

President of CEESTAHC Society, CEO of MedInvest Scanner, Vice President of HTA Consulting. In HTA Consulting, she is responsible for the strategic development of the company through research and services development, new product launch and marketing. Ms. Wladysiuk main and primary aim is to provide high quality information or data based on evidence based medicine or health technology assessment methodology not only in Poland but in Europe and Asia. Key role of her work is to improve patient outcomes through better healthcare decisions. In CEESTAHC she was responsible for the establishing and providing wide connection platform for discussion for all stakeholders in health care system. CEESTAHC mission is to improve the quality of health care systems value with the use of evidence. She graduatd Medical Academy in Lublin and MBA, economy in Kozminski Academy in Warsaw. She was Member of HTAi Annual Meeting in 2006-2008. top

Agnieszka Wojtecka | Poland | 2021

Author of publications on issues related to senior care, active ageing and access to health e-information. Co-author of reports on monitoring public health tasks. Member of research teams and co-author of mid-term ROP 2014-2020 evaluation studies for mid-term review in selected voivodeships. Coordinator of the "Third Age in Health" health promotion programme implemented by the Gdańsk Centre for Health Promotion and Addiction Prevention. Coordinator in a project co-financed by the EU concerning an internship programme for Environmental Health and Public Health students. Psychotherapist. Member of the Polish Society for Health Programs and the Association of Christian Psychologists. top

Marek Wójcik | Poland | 2020 2021 2022 2023 2024

Marek Wójcik, healthcare expert at the Association of Polish Cities, Deputy Minister of Administration and Digitisation in the years 2014-2015, long-term participant of legislative works in the Polish Sejm and Senate; member of the health and social policy team of the Joint Commission of the Government and Local Governments and participant in the work of the Council for Social Dialogue. Since 2004, he has served three terms as chairman of the Council of the Małopolskie Regional Branch of the National Health Fund, an expert to the Minister of Health for restructuring healthcare facilities and ownership transformations (2009-2011), member of the Council for Public Health and of the Scientific Council of the National Influenza Control Programme. He supervises the activities of medical entities subordinate to the Sądecka Municipal Public Services Zone (pilot project), and the Nowy Sącz poviat. Author of publications on public health and health programmes created by local governments. In his didactic activity, he collaborates i.a. with the Cracow University of Economics, Lazarski University in Warsaw, Warsaw School of Economics, Medical University of Łódź, WSB – National Louis University in Nowy Sącz, and University of Business and Entrepreneurship in Ostrowiec Świętokrzyski. top

Wojciech Wysoczański | Poland | 2016

Wojciech is the head of Department of Health Technology Assessment in the Agency for Health Technology Assessment and Tariff System in Poland. Former head of the Pharmaceutical Department at the Central Office of the National Health Fund and former head of the NHF in Dolnośląskie province. He was also the medical director of the Provincial Hospital in Jelenia Góra and hospital in Środa Śląska. He graduated from Wroclaw Medical University and Oskar Lange Wrocław Academy of Economics. top

Michał Zabdyr-Jamróz | Poland | 2024

Political scientist, assistant professor at the Institute of Public Health of the Jagiellonian University Medical College. Collaborator of the European Observatory on Health Systems and Policies (Brussels) and the Partnership for Health System Sustainability and Resilience. Guest lecturer at the University of Copenhagen. Conducted research at, among others: Maastricht and Harvard universities. Presented his research at numerous conferences, including at: Sciences Po in Paris, as well as Universities of Manchester and Canberra. Areas of specialization and interest: health policy analysis; organization of health systems; deliberative democracy and deliberative governance; health equity and theories of justice; health in all policies (HiAP) and health impact assessment (HIA); challenges of evidence-based policy-making; and analysis of public debates on health and the above-mentioned issues. In his approach he utilises deliberative democratic theory, in particular the theory of deliberative systems, and the three inputs of governance framework – analysing intersection of emotions, self-interests and expertise in policy-making. He is also involved in the popularization of research as the founder of the Blog of the Institute of Public Health and the author of numerous popular science press publications. top

Vladimir Zah | Canada | 2016

Vladimir, PhD(c), brings more than 20 years of Health Economics technology and business experience. Since 2000, in various roles as Health Economist, Project Manager and Chief Investigator, Vlad has implemented more than 150 health economic models and assessments in the phase 2, 3 and 4 settings, across various disease areas for top 30 global pharmaceutical companies. Vlad worked extensively over the last 6 years in opioid dependence. His PhD research on early vs. late HIV detection in the United Kingdom contributed to revisions in HIV early detection policies made by the UK Parliament in 2011. He co-founded the Serbian Chapter of the International Society for Pharmaco-economics and Outcomes Research (ISPOR) in 2007 and served as President of that chapter until 2012. Vlad is an active member of various ISPOR special interest groups (SIG) (including rare diseases) and is ISPOR Central East Europe Executive Committee Chair 2015-2017. Vlad lectures extensively and serves as a key opinion leader in the areas of HEOR, opioid addiction, HIV, diabetes and other. He also consults and provided HEOR training relating to both medications and medical devices to Ministry of Health, National Insurance Funds or at national congresses in Russia, Turkey, Greece, Egypt, Poland, Czech Republic, Slovakia, Hungary, Croatia, Bosnia & Herzegovina, Slovenia, FYROM, Republic of Srpska and India. top

Zachary Zalewski | USA | 2022

Zachary Zalewski, PhD, JD is a US regulatory and market access expert trained in biological science and law. Zach currently serves as an Enterprise Strategy Director at the US Pharmacopeia; previously, Zach was a Consultant at Avalere Health, a life sciences advisory firm located in Washington, DC. Zach brings a holistic perspective to healthcare innovation, bridging the gap between science, data, law, and policy. Zach has a JD from Case Western Reserve University with a health law concentration, a PhD in molecular and human genetics from Baylor College of Medicine, and a dual major BS in microbiology and history from Michigan State University. top

Rafał Zasiewski | Poland | 2019

Rafał has been gaining experience and achieving successes in managerial positions in sales and marketing since 1999. For 15 years, he was associated with the Swiss pharmaceutical company Novartis. In 2011, as a leader of an international team of ophthalmic drug managers in Novartis, he built and developed marketing strategies in the Netherlands, Denmark, Norway, Finland, Sweden and Poland. He has introduced projects to optimise operations and manage product strategy in the face of the emergence of competition on the market. Since 2015, he has been co-creating Ideal Datum; the company’s flagship product is Compass Point-Clinics Audit – a consultancy service based on Swiss standards, providing Polish entrepreneurs with a professional tool supporting operational efficiency. As part of his business, he also audits the effectiveness of sales and marketing teams in medical and pharmaceutical companies. top

Wojciech Zawalski | Poland | 2016

Wojciech has been Head of the Department of HealthCare Benefits at the National Health Fund since 2015. He is an active businessman and a specialist in obstetrics and gynaecology. He worked as a doctor in the Dr Madurowicz Provincial Specialist Hospital in Łódź in 1997-2000. He was head of the Gyneacology and Obstetrics Department in Medical Centre in Pabianice in the years 2010-2011. Since 2011 he has worked on management positions in various medical centres. He graduated from the Faculty of Medicine of the Medical Academy in Łódź. In 2013 he finished postgraduate studies in HealthCare Management at the School of Banking and Management in Cracow. top

Jan Zygmuntowski | Poland | 2022 2023

Economist and social entrepreneur interested in complex systems, political economy of technology and digital economy. Co-President of the Polish Network of Economics and Program Director at CoopTech Hub, first Polish center for platform co-ops. PhD candidate at Kozminski University and lecturer at Management and AI in Digital Society program. Founder and 2015-2020 Chairman of the Board at Instrat, a progressive policy think-tank. He gained experience i.a. in the Polish Development Fund. Graduate of the Warsaw School of Economics, fellow of G20 Global Solutions, British Council, Møller Institute, Open Future Foundation & FEPS. Author of “Network Capitalism” (“Kapitalizm Sieci”), nominated to “Economicus 2020” prize. DigitalEU Ambassador. top